The QualityStocks Daily Thursday, May 28th, 2020

Today's Top 3 Investment Newsletters

InvestorPlace (ABIO) +386.33%

StockMarketWatch (HX) +170.83%

SmallCapRelations (NTRR) +136.04%

The QualityStocks Daily Stock List

Ayr Strategies, Inc. (AYRSF)

NetworkNewsWire, mg retailer, InvestorX, Investing News, Investment Pitch, Smarter Analyst, TipRanks, NIC Investors, Midas Letter, OTC.Watch, Barchart, Market Screener, InvestorsHub, Stockhouse, Dividend Investor, Analyst Ratings, GlobeNewswire, OTC Markets, Stockwatch, TradingView, GuruFocus, Newsbreak, and Seeking Alpha reported earlier on Ayr Strategies, Inc. (AYRSF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Ayr Strategies, Inc. is a vertically-integrated cannabis multi-state operator (MSO) with a presence in the western and eastern United States. The Company concentrates on high-growth markets and has anchor operations in Massachusetts and Nevada. Ayr cultivates and manufactures branded cannabis products for distribution through its network of retail outlets and via third-party stores. OTCQX-listed, Ayr Strategies is based in New York, New York.

Ayr’s growth plan is focused on established businesses, best-in-class operators. Concerning its M&A (Mergers & Acquisitions) strategy, it targets limited license States to cluster and penetrate, building regional clusters and brand strength. Its emphasis is on profitability and cash flow. Ayr has five operating companies. Ayr works to create high-quality trusted brands in core geographies for future expansion while pursuing strong organic growth within its existing portfolio.

Ayr Strategies announced in December 2019 that it received final license approval from the Cannabis Control Commission (CCC) to grow cannabis in its earlier completed cultivation facility, as disclosed by the CCC on December 19, 2019. This is Ayr’s second cultivation facility in Milford, Massachusetts. The Company completed its expansion plans in November 2019 to create one of the largest cultivation facilities in Massachusetts. Ayr sells its products to retail and wholesale customers throughout Massachusetts.

Last week, Ayr Strategies reported financial results for the three months ended March 31, 2020. Total Revenue grew 4 percent to $33.6 million versus $32.3 million in Q4 2019. This was driven through early March by higher retail sales in Nevada and higher wholesale revenues in Massachusetts. Revenues declined starting in mid-March because of COVID-related closures and began to rebound in Q2.

Loss from Operations improved to $4.9 million versus $16.9 million in Q4 2019. At March 31, 2020, Cash and Cash Equivalents was $9.9 million, an 18 percent increase versus $8.4 million of Cash and Cash Equivalents at December 31, 2019.

Ayr Strategies, Inc. (AYRSF), closed Thursday's trading session at $8.05, up 0.625%, on 7,978 volume with 52 trades. The average volume for the last 3 months is 32,658 and the stock's 52-week low/high is $3.44000005/$17.8545799.

BioSyent, Inc. (BIOYF)

Stock News Now, Value Forum, Market Screener, Nasdaq, GuruFocus, YCharts, OTC Markets, Investing.com, Dividend Investor, TradingView, 4-Traders, Central Charts, moneyhub.net, GlobeNewswire, Barchart, Stockscores, Investors Hangout, Wallet Investor, Seeking Alpha and Stockhouse reported earlier on BioSyent, Inc. (BIOYF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

BioSyent, Inc. is a specialty pharmaceutical company based in Mississauga, Ontario and listed on the OTC Markets. Via its subsidiaries, it sources, acquires or in-licenses, develops, and sells pharmaceutical and other healthcare products in Canada and around the world. The Company previously went by the name Hedley Technologies, Inc. It changed its name to BioSyent, Inc. in June of 2006 to reflect its forward focus on the pharmaceutical market.

The Company supports the healthcare professionals that treat patients by marketing its products by way of its community, hospital, and international business units. BioSyent continues to search for products to in-license or acquire that are innovative and occupy a niche in the market; provide novel technological or therapeutic advantages to patients and healthcare professionals; and are backed by strong partners who hold defendable intellectual property (IP) rights.

At the beginning of May, BioSyent announced that for the fifth consecutive year, FeraMAX® was named the #1 recommended iron supplement brand in a national survey of Canadian pharmacists and physicians. The 2020 Survey on OTC Counselling & Recommendations was conducted by Ensemble IQ, Research, Insights and Innovation team and the following publications and websites: Pharmacy Practice + Business, The Medical Post, Profession Santé, CanadianHealthcareNetwork.ca and ProfessionSanté.ca. FeraMAX® 150 is an oral iron supplement indicated for the prevention and treatment of iron deficiency anaemia.

Today, BioSyent released a summary of its financial results for the three months ended March 31, 2020. Selected highlights include Q1 2020 Net Revenues of $6,062,846 increasing by 35 percent in comparison to Q1 2019. Q1 2020 Canadian Pharmaceutical Net Revenues of $5,955,561 increased by 39 percent versus Q1 2019.

Q1 2020 EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of $1,997,987 increased by 66 percent in comparison to Q1 2019. Q1 2020 Net Income After Taxes (NIAT) of $1,451,518 increased by 48 percent versus Q1 2019.

BioSyent, Inc. (BIOYF), closed Thursday's trading session at $3.45, up 16.9492%, on 1,920 volume with 6 trades. The average volume for the last 3 months is 6,238 and the stock's 52-week low/high is $2.15050005/$5.82999992.

n

Mandalay Resources Corporation (MNDJF)

Mining Capital, The Prospector News, Proactive Investors, GlobeNewswire, Market Screener, Wallmine, Northern Miner, Stockwatch, Junior Mining Network, OTC Markets, Wallet Investor, TradingView, hot Stocked, TMXmoney, and Morningstar reported on Mandalay Resources Corporation (MNDJF), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

Mandalay Resources Corporation is a natural resource company with producing assets in Australia and Sweden, and care and maintenance and development projects in Chile. It is concentrating on growing production at its gold and antimony operation in Australia, and gold production from its operation in Sweden to generate near-term cash flow. The Company’s mission is to create shareholder value via the acquisition of undervalued assets that can become rapidly cash generative, self fund exploration, establish and maintain high operating margins, and return cash to shareholders. Incorporated in 1997, Mandalay Resources has its corporate office in Toronto, Ontario.

Mandalay Resources operates the 100 percent-owned Costerfield gold-antimony mine in Victoria, Australia. The Company purchased it on December 1, 2009, from Western Coal.

Mandalay Resources acquired 100 percent interest in the Björkdal (Birch Valley) gold mine in September, 2014, when it purchased 100 percent of Elgin Mining. Björkdal is located in northern Sweden, one of the best mining jurisdictions in the world. Björkdal produces gold from a combined open pit and underground operation with roughly 60 percent of plant feed presently delivered from the underground.

This month, Mandalay Resources announced its financial results for the quarter ended March 31, 2020. For the first quarter of 2020, Mandalay generated Revenue of $41.6 million, Adjusted EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of $20.9 million, and an Adjusted Net Income of $5.2 million, or $0.06 per share.

Mr. Dominic Duffy, President and Chief Executive Officer of Mandalay Resources, said, “Mandalay generated excellent financial results, with an all-time record in quarterly adjusted EBITDA at Costerfield of $13.9 million, despite the unprecedented global impacts from COVID-19. Our excellent consolidated financial performance was the result of strong production at both of our mines coupled with higher realized gold prices and a 25 percent decline in cash cost per gold equivalent ounce produced to $846 as compared to the previous quarter result of $1,128…”

Mandalay Resources Corporation (MNDJF), closed Thursday's trading session at $1.49, up 5.6738%, on 27,659 volume with 95 trades. The average volume for the last 3 months is 10,151 and the stock's 52-week low/high is $0.054099999/$1.53100001.

Q BioMed, Inc. (QBIO)

NetworkNewsWire, Market News Updates, Zacks, Insider Financial, last10k, Market Tactic, TipRanks, Barchart, hot Stocked, Market Screener, MacroTrends, Emerging Growth, Wallet Investor, InvestorsHub, Stockhouse, Stockwatch, Wall Street Analyzer, PR Newswire, Simply Wall St, Proactive Investors, and MarketBeat reported previously on Q BioMed, Inc. (QBIO), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

Q BioMed, Inc. is a biotechnology acceleration company based in New York, New York. It acquires, develops and finances undervalued biomedical assets. The Company’s vision is to create a pipeline of unique biomedical assets in different stages of development in numerous therapeutic areas. Its Food and Drug Administration (FDA) approved, non-opioid drug is Metastron. Q BioMed lists on the OTC Markets Group’s OTCQB.

The Company’s Metastron relieves cancer bone pain. Metastron is approved for sale in 21 other countries. Further to treating pain, Metastron has shown evidence of treating the cancer itself and extending survival. Q BioMed’s plan is to conduct Phase IV trials to support label extension and cancer survival benefit using Metastron.

Q BioMed also has its Uttroside-B. Uttroside-B is up to 10 times more potent against liver cancer cells than Sorafenib (preclinical data), the only FDA approved drug for first line treatment of liver cancer. In addition, the Company has its QBM-001 for Pediatric Non-Verbal Disorder in dire need of treatment.

Furthermore, Q BioMed has its Man-01 to treat glaucoma. Man-01 has shown to normalize Intraocular Eye Pressure (IOP) that is present in glaucoma patients. The Mannin platform has a number of potential drugs for treating vascular disease.

Q BioMed announced this past February the launch of its FDA approved non-opioid drug Strontium89 (Strontium Chloride Sr-89 Injection, USP). This drug has been shown in clinical studies to help relieve persistent pain associated with cancer that has metastasized to bone. In several multicenter, placebo-controlled trials in cancer patients with persistent pain after external beam radiation therapy for bone metastases, pain relief occurred in more patients treated with a single injection of Strontium89 than in patients treated with an injection of placebo, with a greater percentage of patients experiencing pain scores of zero without any need for opioid or non-opioid rescue analgesics. Duration of pain palliation has been shown to range from 2 to 5 months in most patients.

Q BioMed plans to launch Strontium89 in global markets, including Europe, in the coming quarters. It is also planning further research for Strontium89 for potential label extension into therapeutic use for survival benefit in metastatic bone cancer through a Phase IV study.

In April, Q BioMed announced that together with its technology partner, Mannin Research, they are accelerating the rapid development of novel drugs for the treatment of life-threatening complications caused by COVID-19 and other viral infections. This novel drug program is undergoing evaluation by government programs for funding and accelerated development under various COVID-19 response initiatives. Q BioMed and Mannin Research hope to have at least one treatment in human trials this year.

This month, Q BioMed announced the launch of its marketing campaign for its FDA approved non-opioid metastatic bone pain drug Strontium89 (Strontium Chloride Sr-89 Injection, USP). A product website for U.S. healthcare professionals and consumers has been launched at Strontium89.com to support Q BioMed's full scale digital marketing program reaching healthcare professionals and patients.

Q BioMed, Inc. (QBIO), closed Thursday's trading session at $1.83, up 0.549451%, on 56,427 volume with 121 trades. The average volume for the last 3 months is 120,959 and the stock's 52-week low/high is $0.34009999/$3.75.

Sailfish Royalty Corp. (SROYF)

Lamp News, SmallCapPower, Seeking Alpha, GuruFocus, Morningstar, Investors Hangout, Gold Stock Data, OTC.Watch, Nasdaq, Wallet Investor, CRWE News, Streetwise Reports, TipRanks, Investors Observer, OTC Markets, Metals News, Stockhouse, Invezz.com, Dividend.com, MarketWatch, Dividend Investor, GlobeNewswire, and Market Screener reported earlier on Sailfish Royalty Corp. (SROYF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Sailfish Royalty Corp. is a precious metals royalty and streaming company. Its intention is to aggressively grow its portfolio and become a yield-focused enterprise through paying dividends to its shareholders. The Company is backed by Wexford Capital LP, a well-funded investor that was part of the creation of Viper Energy Partners LP (Nasdaq:VNOM), a foremost energy royalty company with a US$4.1 billion market capitalization. Sailfish has the ability to invest around the world, with an emphasis on the Americas. OTCQX-listed, Sailfish Royalty is based in Tortola, British Virgin Islands.

Sailfish Royalty has a clear-cut business model. In exchange for an upfront payment, It receives the right to purchase a portion of the gold and/or silver produced from a mine at a fixed price or discount to spot. It receives a portion of the revenue produced from a mine. Sailfish Royalty sells the metal at spot and approximately 90 percent of cash flow is expected to be distributed to shareholders.

Within Sailfish’s portfolio are two foundational assets on advanced stage projects in the Americas. One is a gold stream equivalent to a 3 percent NSR (Net Smelter Return) on the San Albino gold project (about 3.5 sq. km) - mine type: open pit gold mine, followed by underground. The other is a 2 percent NSR on the rest of the area (about 134.5 sq. km) surrounding San Albino in northern Nicaragua. The Company also has an up to 3.5 percent NSR on the Tocantinzinho gold project in the prolific Tapajos district of northern Brazil – mine type: open pit/flotation CIP.

Sailfish Royalty completed the San Albino gold stream restructuring in November of 2018. This eliminated all funding commitments, fast tracked the timeline to cash flow, added more assets (including cash), and provides more exposure to a highly prospective gold district in Nicaragua.

Sailfish Royalty closed the acquisition of Terraco Gold Corp in August of 2019,. This adds a potential cornerstone asset to the portfolio - an up to 3 percent NSR on the multi-million ounce Spring Valley gold project in Pershing County, Nevada.

This week, Sailfish Royalty announced that it retained PI Financial Corp. (PI) to provide market making services in accordance with the TSX Venture Exchange policies. PI will trade the securities of Sailfish Royalty on the TSX Venture Exchange for the purposes of maintaining an orderly market.

Sailfish Royalty Corp. (SROYF), closed Thursday's trading session at $0.651, off by 2.8358%, on 8,500 volume with 9 trades. The average volume for the last 3 months is 12,828 and the stock's 52-week low/high is $0.272000014/$1.32000005.

Seven Generations Energy Ltd. (SVRGF)

Stockhouse, MarketWatch, Lamp News, TeleTrader, Street Insider, MarketBeat, Capital Cube, Wallmine, TradingView, 4-Traders, Stockwatch, Market Screener, GuruFocus, Nasdaq, Wallet Investor, Dividend Investor, Seeking Alpha, and Morningstar reported previously on Seven Generations Energy Ltd. (SVRGF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Seven Generations Energy Ltd. is an independent energy company. It focuses on the development and value optimization of high-quality, tight-rock, natural gas resource plays. The Company is successfully developing its early-stage, multi-decade core development – the Kakwa River Project. Established in 2001, Seven Generations Energy is based in Calgary, Alberta. The Company lists on the OTC Markets.

Seven Generations Energy’s large-scale, liquids-rich Montney natural gas property covers more than 500,000 net acres. It is positioned roughly 100 kilometers south of its operations headquarters in Grande Prairie, in northwest Alberta. The Company employs long-reach horizontal drilling to produce low-supply cost resources of natural gas, condensate, and natural gas liquids (NGLs).

The Montney is a geological formation encompassing 130,000 square kilometers. The formation contains trillions of cubic feet of recoverable natural gas, and billions of barrels of recoverable NGLs, condensate, as well as oil.

The Kakwa River Project is a high-quality property. It contains a large resource base considered sufficient to deliver several years of production growth at a supply cost that is among the lowest in North America. The Nest is Seven Generations Energy’s principal development region. It can sustain between 15-20 years of future development drilling. The Company holds close to 100 percent interest in the Nest and in many surrounding areas. The Nest is characterized by substantial NGLs and condensate.

Seven Generations Energy has secured long-term marketing arrangements for its natural gas. It accomplished this through securing volumes on two transcontinental natural gas pipelines – Alliance and TransCanada – that intersect near the Company’s lands. Today, Seven Generations Energy has varied natural gas market access to markets in Alberta (AECO), Eastern Canada (Dawn), the US Mid-West (Chicago Citygate), the Gulf Coast (Henry Hub), and US West (Malin).

Seven Generations Energy’s Q1 2020 funds flow totaled $275 million with capital investments of $266 million. The wind-down and pause on development capital announced in early March included a temporary suspension of all drilling and completions activities in early April. The Company anticipates resuming field activities towards the end of Q2. Sales volumes were 193,500 boe/d (42% natural gas, 36% condensate, 22% other NGLs) in Q1 of 2020, with natural gas sales of 489 MMcf/d.

2020 production volumes are expected to average 175,000 - 185,000 boe/d. This range is subject to the timing of Seven Generations Energy’s decision to re-start its field activity and the start-up of 11 new wells originally scheduled to start producing in May, now planned for Q3. Start-up decisions will be based on prevailing commodity prices.

Seven Generations Energy Ltd. (SVRGF), closed Thursday's trading session at $2.17, off by 4.4053%, on 55,098 volume with 91 trades. The average volume for the last 3 months is 38,537 and the stock's 52-week low/high is $0.78729999/$7.19600009.

Two Rivers Water & Farming Company (TURV)

Zacks, Stocks Newswire, Daily Marijuana Observer, TipRanks, Investing.com, Market Screener, Green Rush Review, The Marijuana Investor, Simply Wall St, GlobeNewswire, Stockhouse, Nasdaq, Morningstar, Transparent Traders, Investor Village, OTC Markets, GuruFocus, Insider Financial, last10k, Wallet Investor, TMXmoney, and InvestorsHub reported beforehand on Two Rivers Water & Farming Company (TURV), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Two Rivers Water & Farming Company is a vertically integrated agricultural, water rights, and consumer products company. It is pursuing a mission to become a leading hemp-based seed-to-sale operator. The OTCQB-listed Company owns agricultural land and water rights in Southern Colorado where it grows varied strains of hemp with proprietary genetics. Its land and water assets include greater than 2,500 acres of agricultural land and over 1,500 square miles of drain water rights. Two Rivers Water & Farming Company (TURV) is based in Aurora, Colorado.

TURV has a brand portfolio of premium natural supplements. This includes CBD (cannabidiol). Through its consumer brand subsidiary, Gramz LLC, it develops leading products in diverse categories, including CBD. Additionally, the Company has operational expertise in hemp production and distribution. Its subsidiary is Vaxa Global. Vaxa’s management team has decades of experience in agricultural operations. This includes hemp production and manufacturing.

TURV is positioned to grow various strains of hemp with proprietary genetics, to sell bulk biomass, process and extract phyto-cannabinoids and to develop and distribute consumer products. Its plan is to monetize its extensive asset base of land and water through recently acquired hemp companies to form an integrated seed-to-sale enterprise.

In April, TURV and WaterVault America, Inc., an unaffiliated, Colorado Public Benefits Corporation, dedicated to creating sustainable economic development in rural communities, announced that both companies have entered into a Definitive Agreement for WaterVault to acquire water rights of Cucharas Valley No. 05 Dam and Reservoir. TURV agreed to sell their controlling 94.7 percent interest in HCIC Holdings, LLC, which owns 5,062 shares of the 132-year-old, mutual benefit company Huerfano-Cucharas Irrigation Company (HCIC), a mutual irrigation company and owner of water infrastructure assets and infrastructure rights in Huerfano County, including the Cucharas Dam.

Also in April, TURV welcomed Mr. Oscar Tapia Pereira and Mr. Ramon Chimelis to its Board of Directors. These Board members will serve until the next annual meeting of Two Rivers’ shareholders. Mr. Pereira is an Attorney at Law with more than 18 years of practice, with a focus in matters related with Securities Law, Regulation and Commercial and Corporate Law. Mr. Chimelis founded and serves as Principal Executive Officer and Principal Financial Officer at Big Sky Industries II, III, VI, V and VI, Inc. He has been their President, Secretary and Treasurer since January 2000.

Two Rivers Water & Farming Company (TURV), closed Thursday's trading session at $0.0899, up 5.7647%, on 210,862 volume with 27 trades. The average volume for the last 3 months is 340,059 and the stock's 52-week low/high is $0.012/$0.735000014.

Ecoark Holdings, Inc. (ZEST)

NetworkNewsWire, TradingView, TipRanks, Investor Place, TeleTrader, last10k, Whale Wisdom, Wallet Investor, Market Screener, Stockwatch, Morningstar, Insider Financial, GlobeNewswire, Simply Wall Street, Stockhouse, Corporate Information, and Stockopedia reported earlier on Ecoark Holdings, Inc. (ZEST), and we also report on the Company, here at the QualityStocks Daily Newsletter.

Ecoark Holdings, Inc. is an AgTech company modernizing the post-harvest fresh food supply chain for a wide array of organizations. These include growers, suppliers, distributors and retailers. Its wholly-owned subsidiary is Zest Labs™. Zest Labs’™ headquarters is located in the heart of the Silicon Valley, close to many of the world’s most famous agricultural regions. This provides it with quick access to the innovative insights and perspectives of growers, producers and processors.

Formed in 2011, Ecoark Holdings is headquartered in San Jose, California. The Company’s shares trade on the OTC Markets’ OTCQB. Zest Labs offers the Zest Fresh™ solution. This is a leading-edge approach to the quality management of fresh food. It is expressly designed to help substantially reduce the $161 billion amount of food loss the U.S. experiences annually. Through item-level monitoring and real-time predictive analytics, Zest Fresh enables customers to improve the freshness and quality of produce and proteins, realize considerable cost savings, as well as lessen food waste.

Ecoark Holdings’ Zest Fresh solution enables growers, packers, shippers, distributors, and retailers to proactively monitor and manage food freshness in the supply chain. This provides the ability to reduce waste by 50 percent or more and improve product margins by six percent or more.

Ecoark’s Zest Fresh for Produce, Zest Fresh for Protein, and Zest Delivery solutions provide the members of the fresh food supply chain with the information and actionable insights they require to optimize the fresh food supply chain operations to decrease waste. Additionally, they provide the information and actionable insights they require to provide true transparency and supply chain visibility for food safety and authenticity, and the information and actionable insights they need to promote food and environmental sustainability. Furthermore, they provide the information and actionable insights to improve operational efficiency, labor, and asset utilization, and also reduce costs, and increase brand loyalty and create competitive advantage in the marketplace.

Recently, Ecoark Holdings announced that it entered into a definitive agreement to purchase Banner Midstream Corp. from Banner Energy Services Corp. (BANM). This transaction includes the issuance of roughly 8.9 million shares of Ecoark common stock at $0.73 per share, or a 40 percent premium to Ecoark’s March 27, 2020 closing share price of $0.52/share, to Banner Energy for the acquisition purchase in addition to the assumption of roughly $11.2 million in short-term and long-term debt of Banner Midstream.

The combined balance sheet and business fundamentals will strengthen Ecoark Holdings’ planned application to up list to a national exchange. Banner Midstream has four operating subsidiaries. These are Pinnacle Frac Transport LLC, Capstone Equipment Leasing LLC, White River Holdings Corp., and Shamrock Upstream Energy LLC. Banner Energy Services has entered into an agreement to sell its wholly owned subsidiary Banner Midstream Corp. to Ecoark Holdings. Pursuant to the transaction, Ecoark Holdings will issue Banner Energy 8,945,205 shares of common stock and assume $11,161,710 of indebtedness of Banner Midstream.

Ecoark Holdings, Inc. (ZEST), closed Thursday's trading session at $2.27, up 51.3333%, on 1,858,907 volume with 1,933 trades. The average volume for the last 3 months is 445,245 and the stock's 52-week low/high is $0.400000005/$2.47000002.

Cool Holdings, Inc. (AWSM)

Zacks, Stock Twits, PR Newswire, Super Stock Screener, Proactive Investors, Wallet Investor, Guru Focus, MacroTrends, iWatchMarkets, TMXmoney, Stockhouse, Last10k, Morningstar, and InvestorsHub reported earlier on Cool Holdings, Inc. (AWSM), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Cool Holdings, Inc. was created by the March 12, 2018 merger between InfoSonics Corporation and Cooltech Holding, Inc. The Company’s business strategy is to invest in premium retail brands via minority and majority interests, which can enable it to generate profitable growth in revenue and earnings and provide its shareholders with attractive returns. Cool Holdings lists on the OTC Markets Group’s OTCQB. The Company is based in Florida.

At present, Cool Holdings consists of Simply Mac and OneClick, two chains of retail stores and an authorized reseller under the Apple Premier Partner, APR (Apple Premium Reseller) and AAR MB (Apple Authorized Reseller Mono-Brand) programs and Cooltech Distribution, an authorized distributor to the OneClick stores and other resellers of Apple products and other prominent consumer electronic brands.

This past September, Cool Holdings announced that it completed the acquisition of Simply Mac, Inc., from GameStop, Inc. (GME). Simply Mac (Salt Lake City, Utah) is a chain of 41 retail stores across 18 States. The company is an authorized reseller of Apple products and industry-leading high-profile accessory brands. In addition, it is the largest Apple Premier Partner in the United States. Together with its 16 existing OneClick stores, it currently operates 57 retail stores in the United States, Argentina and the Dominican Republic.

Recently, Cool Holdings announced the Grand Opening of its new Simply Mac retail store in Louisville, Kentucky. The opening of this official Apple Premier Partner Store further expands Simply Mac's presence throughout the United States.

This store is 1,640 square feet. It will offer the entire set of Apple products, and also third party accessories and Simply Mac's signature service and warranty repairs on all product categories by its trained team of Apple-certified technicians. Additionally, Simply Mac offers customer financing and extended warranty coverage on all Apple products.

Cool Holdings’ expansion will come from a combination of organic growth and acquisitions. During this, the Company will take advantage of the experience of its team to identify and negotiate leases for the most attractive retail locations and storefronts.

Cool Holdings, Inc. (AWSM), closed Thursday's trading session at $0.1225, up 44.1176%, on 2,016,508 volume with 330 trades. The average volume for the last 3 months is 259,449 and the stock's 52-week low/high is $0.025/$2.47000002.

Right On Brands, Inc. (RTON)

Penny Stock Hub, 4-Traders, InvestorsHub, Morningstar, Investors Hangout, SmallCapVoice, last10k, Interactive Brokers, MarketWatch, OTC Markets, Wallet Investor, YCharts, Simply Wall St, Barchart, Stockhouse, Capital Cube, Penny Stock Vault, Stockwatch, Stockopedia, and Investors News Magazine reported earlier on Right On Brands, Inc. (RTON), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Right On Brands, Inc. is a consumer goods company based in Santa Monica, California. It specializes in the brand development of health conscious, hemp-infused food and beverage products. Right On Brands consists of three subsidiaries. These are Endo Brands, Humble Water Company, and Humbly Hemp. Right On Brands’ shares trade on the OTC Markets.

The Company is developing, marketing, and investing in industrial hemp, cannabis, adaptogenic superfoods and natural water for a new generation of health-conscious consumers. Endo Water is pH balanced and micro-clustered for antioxidant protection. Additionally, Endo Water is oxygenated for improved performance and energy.

Endo Water is infused with a 99.5 percent pure CBD oil, processed using Nano Technology. This makes the particles one-millionth of its normal size. The process permits the Nano-Sized CBD's to immediately penetrate one’s cells versus the lengthy process of being absorbed by the body's digestive system.

Right On Brands created a joint venture (JV) with Centre Manufacturing, LLC to create ENDO Labs. ENDO Labs was established to fill the void in the hemp derived CBD market for the creation and manufacturing of quality formulated CBD products. ENDO labs can formulate food, beverage, skin-care/topical, supplements, and pet. It can also take on advanced formulations and products to any customers’ preference. ENDO Labs will also have the function of brokering CBD oil for its customers and clients. Right On Brands has 51 percent ownership of the JV with Medical Biochemist Dr. Ashok Patel's Centre Manufacturing.

Humbly Hemp is a product line of hemp-based products. Each Humbly Hemp bar is kosher, vegan, soy free, dairy free, and gluten-free. Furthermore, they are free of all top 11 allergens. The foundation of Right On Brands’ protein bars is with gluten free rolled oats, hemp seeds, and plant protein.

The Humble Water Company product is a natural spring water sourced from an ancient ice age aquifer at the foothills of the Rocky Mountains located at the only triple watershed in North America. Humble Water is pure and high in natural alkalinity.

Recently, Right on Brands announced it will be entering the lucrative health and wellness business with one of the Southwest's first full-service CBD based wellness centers. The corporate showcase ENDO Wellness Center is scheduled to open summer 2019 in Dallas, Texas. Right on Brands/Endo Brands, Inc, the maker of Endo Water will also be opening a regional distribution warehouse in Addison Texas on Midway Lane later this month.

Right On Brands, Inc. (RTON), closed Thursday's trading session at $0.0003, up 50.00%, on 339,595,853 volume with 197 trades. The average volume for the last 3 months is 17,807,114 and the stock's 52-week low/high is $0.000097999/$0.036449998.

Leading Edge Materials Corp. (LEMIF)

InvestorsHub, MarketWatch, Stockhouse, Metals Channel, 4-Traders, Investing News, Penny Stock Tweets, Wall Street Analyzer, Metals News, Market Screener, and Investor Place reported earlier on Leading Edge Materials Corp. (LEMIF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Leading Edge Materials Corp. concentrates on the production of high value critical raw materials for the European market. It has an operating base in the Nordic region. The Company’s flagship asset is the Woxna Graphite production facility in central Sweden targeting the supply of specialty materials for lithium ion battery production. OTCQB-listed, Leading Edge Materials is based in Vancouver, British Columbia.

The Company operates in four divisions: Graphite, Lithium, Rare Earth and Cobalt. Leading Edge’s assets and research focus are towards the raw materials for Li-ion batteries (graphite, lithium, cobalt); materials for high thermal efficiency building products (graphite, silica, nepheline); and materials that improve the efficiency of energy generation (dysprosium, neodymium, hafnium). Its investments are linked to the global shift to low-carbon energy generation and energy storage.

Leading Edge Materials has 100 percent ownership of industry-leading assets in the Nordic region. It has 100 percent ownership of graphite, cobalt, lithium and rare earth element deposits across three mining supportive jurisdictions. In addition, the Company has a unique position in the sustainable supply of critical materials for the high growth lithium ion battery market.

Leading Edge Materials has its Romanian Exploration Alliance. The Exploration Alliance is focused on the discovery and development of lithium ion battery raw materials. The main efforts of the Exploration Alliance as of early November 2018, was directed towards cobalt mineralization within the Upper Cretaceous Carpathian magmatic belt of the Balkan region.

In January, Leading Edge Materials provided a summary of test work conducted on graphite from its 100 percent owned Woxna mine in Sweden during last year. With the test program complete, the Company is now moving ahead to an engineering study supporting the installation of a Battery Graphite Demonstration Plant at the Woxna site. The demonstration plant, when installed, will enable process conditions to be optimized and larger volumes of natural graphite anode material to be supplied to prospective lithium ion battery customers.

Leading Edge Materials is advancing a portfolio of European battery raw material projects. These include the fully built and permitted above-mentioned Woxna graphite mine in Sweden, the Bihor Sud cobalt-copper-nickel project in Romania, and the Norra Kärr heavy rare earth element-zirconium-hafnium deposit. All are high merit projects within the European raw material sector.

The Company’s internal corporate Strategic Review firstly highlighted that Leading Edge's combination of discovery-stage and development-stage assets may present different requirements concerning operational structure, capital needs and investor preferences. The Board resolved that the next stage of the Strategic Review will identify and compare opportunities for the Woxna graphite mine.

Potential recommendations from this stage of the Strategic Review may include a transition to a freestanding European company. Additionally, it will consider direct third-party investment into Woxna, horizontal or vertical joint-venture of with aligned parties, or a standalone public listing of Woxna on a Swedish exchange. The Board cautions that there is no assurance or guarantee that any potential transaction identified by the Strategic Review will be pursued.

Leading Edge Materials Corp. (LEMIF), closed Thursday's trading session at $0.09465, up 47.8906%, on 167,719 volume with 41 trades. The average volume for the last 3 months is 60,519 and the stock's 52-week low/high is $0.029999999/$0.300000011.

Aerpio Pharmaceuticals, Inc. (ARPO)

Market Chameleon, Hot Stock Cafe, High Rising Stocks, Street Insider, Stocktwits, 4-Traders, Barchart, Zacks, Business Wire, OTC Markets, Morningstar, OTC Stock Picks, Insider Tracking, and MarketWatch reported beforehand on Aerpio Pharmaceuticals, Inc. (ARPO), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

Aerpio Pharmaceuticals, Inc. focuses on first-in-class treatments for ocular diseases. The Company’s lead compound is AKB‐9778. This is a small molecule activator of the Tie2 pathway. It is in clinical development for the treatment of non-proliferative diabetic retinopathy. A biopharmaceutical Company, Aerpio Pharmaceuticals has its corporate office in Cincinnati, Ohio. The Company lists on the NasdaqCM.

Currently, AKB-9778 is in a Phase 2b study (TIME-2b)  for the treatment of  non-proliferative diabetic retinopathy (NPDR). Diabetic Retinopathy (DR) is a complication of diabetes caused by damage to blood vessels in the retina. AKB-9778 is undergoing development as a subcutaneous injection.

Aerpio Pharmaceuticals’ second program in development builds on its unique approach to targeting the Tie2 pathway. ARP-1536 is a humanized monoclonal antibody. It works by binding the extracellular domain of VE-PTP, inhibiting its ability to interact with the Tie2 receptor. This prevents the inactivation of Tie2. In addition, it promotes vascular stability.

ARP-1536 is in pre-clinical development. Aerpio’s plan is to develop ARP-1536 in combination with anti-VEGF therapy for the treatment of wet age-related macular degeneration (AMD)  and diabetic macular edema (DME). Furthermore, AKB-4924 is in Phase 1 clinical development. The Company’s plan is to develop it as a once-daily, oral treatment for inflammatory bowel disease (IBD). AKB-4924  is an innovative small molecule inhibitor of prolyl-hydroxylase domain enzymes (PHDs).

Aerpio Pharmaceuticals announced the completion of patient dosing in its TIME-2b study. This is the aforementioned Phase 2b clinical trial designed to assess the efficacy and safety of the Company’s lead candidate, AKB-9778, for patients with moderate to severe non-proliferative diabetic retinopathy (NPDR).

Stephen Hoffman, M.D., Ph.D., Chief Executive Officer of Aerpio Pharmaceuticals, said, "We are pleased to announce completion of patient dosing in our 48-week Phase 2b trial, TIME-2b. We now expect to announce top-line results in March 2019, earlier than our previous guidance of the second quarter of 2019.”

Recently, Aerpio Pharmaceuticals announced that its Q4 and full year 2018 financial results will be released before the market opens on Tuesday, March 5, 2019. Following the release, Aerpio will host a live conference call and webcast at 8:30 a.m. EST to discuss its financial results and provide a general business update.

Aerpio Pharmaceuticals, Inc. (ARPO), closed Thursday's trading session at $1.13, up 44.5013%, on 65,419,161 volume with 119,380 trades. The average volume for the last 3 months is 779,693 and the stock's 52-week low/high is $0.419999986/$1.52999997.

ReelTime Rentals, Inc. (RLTR)

MarketWatch, Stockhouse, Marketwired, WalletInvestor, Penny Stock Hub, Barchart, Simply Wall St, Penny Stock Tweets, 4-Traders, InvestorsHub, and OTC Markets reported on ReelTime Rentals, Inc. (RLTR), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

ReelTime Rentals, Inc. (d/b/a ReelTime VR, ReelTime Media Group) is a multimedia publishing business. The Company engages in helping individuals that have been thrust into the public eye to monetize their exposure and control the portrayal of their story. In addition, it develops, produces, and distributes Virtual Reality (VR) Content and technologies under the brand ReelTime VR. ReelTime is headquartered in Seattle, Washington and lists on the OTC Markets.

ReelTime has end to end production, editing, and distribution capabilities for internal and external projects. At present, the Company produces three ongoing series for the Samsung Gear VR platform, VeeR TV, Oculus. It distributes them over manifold VR delivery sites.

Regarding Partnerships, ReelTime partners with other top VR distributors, content producers, and technology providers. Furthermore, concerning its Services, the Company offers Consulting, Production, Monetization, VR Set Design, VR Media Campaigns, as well as VR Content Production.

Pertaining to VR Set Design, ReelTime has a totally-dressed virtual set in its studio facilities. It can create any look one wants for their Virtual Reality show. Also, it can provide traditional virtual set backdrops.

Concerning VR Content Production, ReelTime has a team of editors and other pre/post-production professionals available for all elements of producing VR content. This is from the initial design concepts, to pixel-perfect deliverables.

ReelTime VR announced recently that it became the first to utilize a proprietary technology developed by the Company that allows it to film in full 360 x 360 Virtual Reality formats and simultaneously film in formats compatible with traditional Television platforms. This will allow ReelTime VRs shows the Company produces to not only be available on the rapidly growing premium VR sites it is currently available on, but it will additionally be available for distribution over mainstream Network Television formats and worldwide.

ReelTime has received patent-pending status from the United States Patent and Trademark Office (USPTO) for its non-provisional patent application encompassing apparatus and method claims for technology involving simultaneous capturing of 360 X 360-degree Spherical Panorama Images and Video. The technology will enable any cell phone or other camera to promptly capture 360 X 360 Virtual Reality Video or pictures without any need for stitching.

The VR content is compatible with and can be shared through 360 capable social sites in real time, and on any professional VR platform such as Oculas, Gear VR, Veer VR, Playstation VR, Littlstar, and the HTC Vive.

ReelTime will start using this inventive technology in its production of its award-winning Virtual Reality travel series “In Front of View”. The series commenced filming its second season in Thailand in July. It is shot in English and in Thai. Moreover, ReelTime VR is entertaining licensing agreements with select other VR, film, and TV producers to allow them to also gain a competitive advantage.

ReelTime Rentals, Inc. (RLTR), closed Thursday's trading session at $0.029, up 56.7568%, on 1,509,532 volume with 106 trades. The average volume for the last 3 months is 41,451 and the stock's 52-week low/high is $0.0043/$0.05.

Monaker Group, Inc. (MKGI)

MissionIR, Serious Traders, Tiny Gems, Tip.us, SmallCapVoice, StocksToBuyNow, Trader Power News, and Wall Street Mover reported previously on Monaker Group, Inc. (MKGI), and we also report on the Company, here at the QualityStocks Daily Newsletter.

Monaker Group, Inc. is a technology-driven travel company listed on the OTC Markets Group’s OTCQB. The Company has numerous divisions and brands, leveraging more than six decades of operation in leisure travel. Monaker Group is the parent company of Maupintour and Next Trip, both leaders in travel. Monaker Group is based in Weston, Florida.

Monaker’s companies include the above-mentioned Maupintour and Next Trip, along with EXVG (Extraordinary Vacation Group), and Voyage.tv. The Companies B2B platform provides travel distributors and agencies a Customizable Real-Time booking platform for Alternative Lodging Rentals (ALR) (apartments, vacation homes, resort residences).

Voyage TV has access to thousands of hours of travel footage shot in more than 30 countries. There is greater than15,000 clips of hotels, resorts, and cruise and destination activities.

The Company’s B2C platform will be the first to provide real-time ALR products along with mainstream travel products and services, all on a single site. NextTrip.com will provide multiple booking platforms, all combined into one user-friendly experience. Next Trip will include hotel, vacation home rentals, resorts, cruises, flights, tours, activities, and car rentals all in one place.

Next Trip is powered by the Monaker Booking Engine (MBE). This is a new cloud-based technology platform. It delivers ALR reservations that can be immediately confirmed.

MBE delivers Monaker's global ALR inventory via a flexible application program interface (API), which also supports the distribution of Monaker's ALR products to its B2B travel industry partners. The Monaker Booking Engine and API are built to the latest industry standards. This allows for custom integration into almost any existing booking system.

Next Trip will serve the entire travel range with travel licenses. These include ARC, IATA, and CLIA & Florida Seller of Travel. Next Trip is the first travel service to offer all its ALR properties as immediately bookable.

The Extraordinary Vacations Group (EXVG) platform allows timeshare owners the ability to market their unused timeshare, fractional, condo-hotel units to travelers. EXVG provides a number of unique advantages with a particular concentration on resort properties. It gives its customers and partners’ premier choices for the best vacation destinations at the lowest possible prices.

Recently, Monaker Group announced it became the exclusive provider of alternative lodging rentals (ALRs) to Exponential, a cause-related technology marketing enterprise. Exponential offers a white-label e-commerce platform, XPO² that boots fundraising revenue on behalf of affinity groups, charities, as well as NGOs internationally.

A new partnership agreement between Exponential and Monaker Group provides for the integration and launch of the Monaker Booking Engine (MBE) on the XPO² platform, and promotion of the ALRs that Monaker delivers. Deployments of the XPO² platform will prominently display Monaker Group's vacation lodging rentals and other travel products.

Propelled by proprietary technology, MBE controls exclusively-contracted properties. This permits users to search and immediately book reservations for alternative lodging.

Monaker Group, Inc. (MKGI), closed Thursday's trading session at $1.56, up 47.1698%, on 165,834 volume with 716 trades. The average volume for the last 3 months is 11,056 and the stock's 52-week low/high is $0.610000014/$3.26999998.

The QualityStocks Company Corner

Pressure BioSciences Inc. (PBIO)

The QualityStocks Daily Newsletter would like to spotlight Pressure BioSciences Inc. (PBIO).

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide biotechnology, biotherapeutics, cosmeceuticals, nutraceuticals, and food & beverage industries, today announced that its pending merger partner Cannaworx, Inc. will be launching its patented and proprietary immune booster supplement by mid-July 2020. To view the full press release, visit http://cnw.fm/Jbv9j. Also today, the company was highlighted in a publication from FinancialNewsMedia.com, examining how there is an ever increasing amount of data that appears to show that we have not yet grasped… scientifically… the full medicinal uses of Cannabis and Cannabinoids. Some of the more recent studies are focusing in on CBD can strengthen the immune system. A recent article by CBDClinicals, looks into why people are turning to CBD to strengthen their immune system. 

Pressure BioSciences Inc. (PBIO) develops, markets and sells proprietary laboratory instrumentation and associated consumables to the life sciences sample preparation market. Sample preparation refers to the wide range of activities that precede most forms of scientific analysis. It is often complex and time-consuming, yet a critical part of scientific research. The market for sample preparation products is currently estimated at $6 billion worldwide.

The Company’s product line can be used to exquisitely control the sample preparation process. It is based on a patented, enabling technology platform called pressure cycling technology (“PCT”). PCT uses alternating cycles of hydrostatic pressure between ambient (14.5 psi) and ultra-high levels (up to 100,000 psi) to safely and reproducibly control critical biological processes, such as the lysis (breakage) of cells, the digestion of proteins, and the inactivation of pathogens.

Pressure BioSciences’ product line is led by its newly released, next-generation Barocycler 2320EXTREME instrument. Named a finalist in the prestigious 2017 R&D Awards (also known as the “Oscars of Innovation”), the Barocycler 2320EXT is already being touted by some key opinion leaders as an essential element of the $1.8 billion U.S. “Cancer Moonshot” program. For example, Professor Phil Robinson, Co-head of the cancer research center of the Children’s Medical Research Institute (Sydney, Australia), said in a recent interview: “We are collecting the whole proteome on 70,000 tumor samples from all classes where complete clinical outcome is known. Due to its unique capabilities, the Barocycler 2320EXT has become a critical part of our program. It is the primary enabler of the high-throughput component of the project. Without this step, our project simply could not be done. In fact, the Barocycler 2320EXT works so well we have just purchased two more.”

Momentum is building when it comes to the potential for using the Company’s unique PCT technology platform. Leading scientists are intrigued by Pressure BioSciences’ approach, which among other attributes, revolutionizes the process of rupturing cells (lysis) for further study, yielding superior biomolecules for investigation. The Company’s technology transcends current methods of breaking open cells, which use chemicals, blades, metal beads, or other damaging and altering methods that can ultimately adversely affect the result for researchers. Pressure BioSciences’ PCT technology utilizes customized, controlled hydrostatic (water) pressure to rupture cells in a chamber, enabling exquisitely customized levels of pressure to optimally break open different types of cells at prescribed pressure levels—something never before accomplished in a commercial setting. Using this pioneering method, the result is a truer, more legitimate sample, which boosts the efficacy of research and the quality of results. The potential impact of this technology on scientific advancement is enormous, enabling research scientists to begin their studies with biological samples of unprecedented integrity, with the potential to improve research outcomes at the earliest, most critical step. PCT can additionally inactivate pathogens (e.g., viruses, bacteria) using hydrostatic pressure, making the samples safer to study—another innovation with astronomical potential for application in a variety of markets.

The Company’s high-pressure instruments for research purposes are marketed throughout the United States, Europe, China and Japan. To date, Pressure BioSciences has installed nearly 300 PCT Systems in over 165 leading academic, government, biotech and pharma laboratories around the world. Its primary applications are in biomarker discovery, forensics, agriculture and pathology. Over 100 scientific papers have been published on the advantages of the PCT platform, which is also being used in the specialized fields of drug discovery and design, bio-therapeutics characterization, soil and plant biology, vaccine development and histology.

Impressive as their biotech business is, there is more to the PBI story. Pressure BioSciences recently received two patents in China for its novel Ultra Shear Technology (UST), a process that has potential in a wide range of industrial applications, including extending the shelf life of some food products and making two insoluble liquids (like oil in water) soluble. Patents have also been filed in many other countries worldwide. UST is a novel technique based on the use of intense shear forces generated from ultra-high-pressure valve discharge.

This important technology has the potential to play a significant role in a number of commercially important areas through its ability to create high-quality, stable nanoemulsions. Scientific studies indicate that improved absorption, higher bioavailability, greater stability, lower surfactant levels and other advantages can be achieved with nanoemulsions – all hugely important factors in the fields of nutraceuticals, cosmetics, pharmaceuticals, and in various medical products. There is an enormous opportunity in the cannabis market, since the technology can potentially reduce oil droplets containing cannabidiol (CBD) to nanoparticles, after which they can be safely suspended in a stable water solution—something many companies have endeavored to achieve without success. Researchers looking for a way to increase the bioavailability of cannabinoids in the body will find this technology a game changer.

The Company’s UST technology also has possibilities in the production of clean label foods, which are currently processed using several innovative methods, including high-pressure treatments (such as Starbucks’ Evolution line of juices). In 2015, the worldwide market for high-pressure processed (HPP) food was estimated at U.S. $10 billion. UST uses ultra-high pressures and certain valves to generate intense shear forces under controlled temperature conditions to produce nanoemulsions, and which also significantly reduces food-borne pathogens. Pressure BioSciences’ initial focus with this technology will be to evaluate UST for the production of high-quality dairy products and beverages.

Pressure BioSciences Inc. (PBIO), closed Thursday's trading session at $2.58, up 14.6667%, on 77,557 volume with 145 trades. The average volume for the last 3 months is 14,814 and the stock's 52-week low/high is $0.600600004/$4.48999977.

Recent News

Plus Products Inc. (CSE: PLUS) (OTC: PLPRF)

The QualityStocks Daily Newsletter would like to spotlight Plus Products Inc. (CSE: PLUS) (OTC: PLPRF).

Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) was featured today in the 420 with CNW by CannabisNewsWire. When governments issued lockdown and social distancing orders to curb the spread of the coronavirus, most states with legal marijuana programs deemed cannabis an essential service, allowing both recreational pot shops and medical marijuana dispensaries to continue operating. In Massachusetts, however, only medical marijuana shops were deemed essential, forcing residents who wanted to indulge in recreational pot during the lockdown to turn elsewhere. With the state slowly reopening, recreational marijuana retailers have been allowed to reopen since they were forced to shut down in March due to the coronavirus pandemic. Also today, the company released its unaudited financial and operational results for the three months ended March 31, 2020, expressed in U.S. dollars. These filings are available for review on the Company’s SEDAR profile at www.sedar.com and on the Canadian Securities Exchange (the “CSE”) website at www.thecse.com.

Plus Products Inc. (CSE: PLUS) (OTC: PLPRF) is a branded cannabis-infused products manufacturer of edibles created to support a healthy and active lifestyle. Headquartered in San Mateo, California, PLUS™ concentrates on producing edibles using extracts to ensure compliant, dosable and delicious products that provide a consistent cannabis experience.

First introduced to the market in 2015 to rave reviews, PLUS™ is now one of the top best-selling edible brands in California. PLUS™ operates through a wholly owned subsidiary, Carberry, and has four cannabis-infused gummy candy SKUs (in addition to limited edition SKUs), that are currently sold in over 200 licensed dispensaries and delivery services. All products under the PLUS™ brand are produced in the company’s 12,000-square-foot food-safe cannabis manufacturing facility in Adelanto, California.

PLUS Products shares are currently listed on the Canadian Securities Exchange. PLUS™ raised CAD$20 million through the offering, for which the lead underwriters were PI Financial and Canaccord Genuity. The company intends to use a portion of the IPO proceeds to fund rapid product capacity expansion, factory automation, working capital and new product development.

Operating in the largest adult-use recreational market in the U.S., PLUS Products holds a temporary manufacturing license in California and was one of the first brands to bring fully compliant products to the legal market. California legalized adult use recreational sales on Jan. 1, 2018, and industry analysts expect edible sales there will continue to amass enviable revenues. According to BDS Analytics, edibles made up 18 percent of marijuana retail sales in February 2018 across licensed retailers in California, with PLUS™ products ranking in the Top 10 of edible brands by retail dollar sales.

During the first half of 2018, PLUS Products generated US$2.45 million in sales, a marked improvement over 2017’s US$1.07 million in sales. The company’s established cannabis products are not only compliant with state laws, they are proving to be extremely popular with consumers. Among the PLUS™ product brands are:

  • Blackberry & Lemon RESTORE, an infusion of carefully dosed cannabis with a 9:1 THC to CBD per gummy.
  • Sour Watermelon UPLIFT, a low-calorie gummy crafted from carefully dosed cannabis with an infusion of 5mg THC per gummy.
  • Pineapple & Coconut CBD RELIEF, a tropical flavor gummy made from pure cannabis-derived CBD that is low-calorie, gluten-free and made with kosher ingredients.
  • Sour Blueberry CREATE, a low-calorie gummy infused with hybrid flower containing 5 mg THC.
  • Limited Edition Rose & Vanilla, available at select locations during Winter 2018, these gummies are crafted with 60 mg THC/30 mg CBD per tin.
  • Limited Edition RAINBOW SORBET gummies was created to celebrate Pride during Spring 2018 with a portion of each purchase donated to The Trevor Project, a confidential suicide hotline for LGBT youth.

“We are extremely proud of the products PLUS has brought to market,” remarked Jake Heimark, CEO and cofounder in a statement. “We’ve quickly grown into one of the leading edible brands in California. With the proceeds of this round, we will continue to further our mission: to make cannabis safe and approachable for all types of consumers.”

The PLUS™ team believes that everyone deserves access to consistent, dosable and delicious cannabis products and strives to make that happen. Producing the best infused products at scale requires thoughtful collaboration among experts in many fields. At PLUS™, our team is comprised of Chefs, Chemists, Food Manufacturing Experts, Engineers, Machinists, Visionaries, Creatives, Strategists and others.

Plus Products Inc. (PLPRF), closed Thursday's trading session at $0.7378, up 9.3847%, on 50,252 volume with 47 trades. The average volume for the last 3 months is 37,613 and the stock's 52-week low/high is $0.279000014/$4.03999996.

Recent News

PowerBand Solutions Inc. (TSXV: PBX) (OTCQB: PWWBF) (Frankfurt: 1ZVA)

The QualityStocks Daily Newsletter would like to spotlight PowerBand Solutions Inc. (TSXV: PBX) (OTCQB: PWWBF) (Frankfurt: 1ZVA).

PowerBand Solutions (TSX.V: PBX) (OTCQB: PWWBF) (Frankfurt: 1ZVA) recently developed a partnership with Source Digital, a pioneer in immersive commerce using digital-media platforms and video content on the internet. To view the full article, visit http://nnw.fm/48aUA

A Better Way to Connect and Acquire Vehicles

PowerBand’s mission is to create an online, consumer-directed marketplace that streamlines the interactions among all participants in the automotive industry. It transforms today’s antiquated business model with speed, transparency, access to information and ease of use for consumers and dealers.

Consumers can easily connect with new sources to buy vehicles, network with motivated buyers and sellers, maximize their trade-in values, improve their customer experience. PowerBand’s standardized system and transaction process also increase efficiencies and benefits with hands-on, process-driven, in-store training and support.

Through internal development, acquisitions, joint ventures and strategic partnerships, PowerBand is developing solutions for consumers, dealers, manufacturers, commercial customers and lenders that are poised to transform the trillion-dollar U.S. automotive industry.

The PowerBand Auto Platform

PowerBand’s transaction platform was developed by a team of experienced automotive, technology and finance experts, and has been refined through years of operational experience. Built on the core belief that the consumer prefers to primarily conduct automotive transactions online and avoid interactions with unnecessary middlemen, PowerBand’s product solutions include:

  • Leasing: PowerBand is currently licensed in 33 U.S. states via a majority interest in MUSA Auto Finance LLC, an advanced online leasing technology platform that has transformed the new and used vehicle leasing industry. A partnership with Tesla was recently finalized, making MUSA the only approved, non-captive lease partner for Tesla in the U.S.
  • Inventory and Financing: A partnership with RouteOne LLC, a leading financial platform founded in 2002 by Ally Financial, Ford Motor Credit Co., TD Auto Finance and Toyota Financial Services, allows access to a network of more than 18,000 dealerships and 1,400 financing sources.
  • Auction Platform: PowerBand and its joint-venture partner, D2D Auto Auctions, are developing a direct consumer-to-dealer and a consumer-to-consumer automotive portal, which will provide an innovative alternative to physical dealership and auction locations.
  • LiveNet Auction: An online platform portal that allows dealers to create instant live vehicle auctions to a vast network of the industry’s top used vehicle buyers.
  • MarketPlace Auction: An online listing auction site for buying and selling automotive inventory – ideal for dealers, fleet, OEM and rental companies.
  • Used Vehicle Inspections: An LOI agreement with TÜV NORD Mobility Inc., a German-based global leader in vehicle inspections operating in more than 70 countries, will provide the most comprehensive, certified vehicle inspection reports available in North America. Appointments booked within the platform can be performed nearly anywhere.
  • Product Development: PowerBand’s comprehensive consumer solution, Driveaway, will be a fully transactional consumer marketplace where dealers and consumers can buy, sell, trade-in and finance vehicles, often in seconds, from the comfort of their home.

Automotive’s Growing Markets

The automotive dealership and commercial fleet vehicle auction industry is a $100-billion sector with more than 40 million used vehicles transacted in the U.S. each year. Of those, ten million are sold through auctions. From 2013 to 2017, the growth of online-only auctions far outpaced physical auctions, growing at a 33% compound annual growth rate compared to 2% CAGR at physical auctions.

Automotive leasing is another large, growing and fragmented market, generating approximately $120-billion in annual revenue. As a percentage of vehicle sales, leasing reached 30% in 2018, up from 21% in 2012, and is seen as a substantial opportunity for PowerBand and MUSA Auto Finance. Using proprietary technology and by focusing on high-quality, credit-worthy customers, MUSA grew its automotive lease originations to $182 million.

Disrupting Auto Leasing with MUSA

Legacy solutions are complicated, expensive and slow at processing leases. MUSA’s first-of-its-kind technology platform eliminates third-party decisions and the human capital required in the underwriting process. MUSA’s platform navigates the entire customer experience – underwriting, funding and the delivery process – within minutes. Leases can be approved in seconds.

PowerBand’s acquisition of MUSA brings together two leading-edge companies with the vision to become a one-stop platform for the entire vehicle purchase lifecycle.

Experienced Leadership

PowerBand is led by a collection of automotive veterans with a passion to collectively and positively impact the industry.

  • Kelly Jennings, president and CEO, is the founder of PowerBand Solutions and a franchise dealer owner/operator with more than 27 years of automotive experience. Jennings received General Motor’s Triple Crown Award, Ford Motor Company President’s Award and Honda Canada’s Excellence Award.
  • Darrin Swenson, COO of PowerBand and D2D Auto Auctions/Hunt Automotive Group, has more than 25 years of automotive/auction experience.
  • Jeff Morgan, CEO MUSA, holds over 25 years of experience in the auto finance sector.

 

PowerBand Solutions Inc. (OTCQB: PWWBF), closed Thursday's trading session at $0.13435, up 34.6867%, on 34,410 volume with 5 trades. The average volume for the last 3 months is 37,666 and the stock's 52-week low/high is $0.038600001/$0.230000004.

Recent News

Kingman Minerals Ltd. (TSXV: KGS)

The QualityStocks Daily Newsletter would like to spotlight Kingman Minerals Ltd. (TSXV: KGS).

Kingman Minerals (TSX.V: KGS) (FSE: 47A1) today announced that it is currently in the process of preparing a NI43-101 compliant technical report on the Mohave Project. According to the update, in 2020, Burgex Mining Consultants was contracted to determine accessibility of the Rosebud Mine and complete two underground sampling programs, the results of which will be implemented into the NI43-101 technical report. To view the full press release, visit http://nnw.fm/bd93N

Kingman Minerals Ltd. (TSXV: KGS), formerly Astorius Resources Ltd., is engaged in the acquisition, exploration and development of gold and silver properties in North America. The Canada-based company is focused on sourcing and developing high-quality properties in favorable mining locations to advance its diverse portfolio of low-cost, lifelong assets.

Kingman Mine

The Company maintains the following projects:

The Mohave Project: Located in the Music Mountains in Mohave County, Arizona. Approximately 35 miles from the town of Kingman, the property consists of 20 lode claims, including the historic Rosebud Mine. The Company has entered into an option agreement to earn 100% over four years. According to historic mappings of the mine, probable ore is 15,560 tons. Possible (inferred) ore is comprised of 176,000 tons, and additional possible (inferred) ore totals slightly over 1,100,000 tons. The total contained gold ounces for all categories is estimated at 664,000 ounces, and contained silver is estimated at 2,600,000 ounces. The Company has recently completed two underground reconnaissance and sampling programs and is in the process of verifying previous resource estimates.

 

The Cadillac East Property: Located approximately 55 kilometers east of Val d’Or, a hub for exploration and mining activities in the Canadian province of Quebec. The Company acquired a 100% interest in the property from an arm’s length vendor. Cadillac East Property consists of 12 claims, and the Company has an option agreement to earn 100% over three years. Having been the subject of numerous geophysical and geological surveys, the Cadillac East Property has been explored and surveyed by numerous companies as well as by the Quebec government. Exploration work done in 2017 by Exploration Facilitation Unlimited Inc. revealed multiple potential targets for future investigation, as results from the soil program identified value in gold, silver, copper, zinc and nickel.

Kingman Minerals is focused on enhancing shareholder value as it continues exploring potential assets and acquiring strategic gold targets. The company recently commissioned mining consulting services company Burgex Mining Consultants Inc. to complete two underground gold exploration programs in the historic Rosebud Mine. Burgex specializes in mineral exploration, mining claim staking, landman services, mining consulting, and the access and documentation of abandoned mine sites throughout the western United States and the world. Burgex’s founders have been active in the industry since 2007 and have identified, secured and consulted on hundreds of thousands of acres of mineral properties spanning a wide range of mineral commodities with billions of dollars’ worth of resources and reserves. The Burgex team has been featured in Forbes Magazine as well as on the Discovery Channel and other outlets. Burgex is at the vanguard of industry advancements in safely accessing difficult vertical abandoned mine workings and continues to pioneer new mineral exploration methods with strategic partners throughout the United States and the world.

Gold’s Predicted Rise

The value of gold is currently on an upward climb due to COVID-19’s upending of the global economy, causing governments to expand their balance sheets. In 2019, as a result of the housing and financial crisis, gold saw its best performance since 2010increasing as much as 20% and hitting a top price of $1,549 per ounce in September of that year. Analysts predict its price will continue to climb due to strong buying by central banks, a weakening of the U.S. dollar, and increasing political tensions. A recent Wolfe Research report predicted gold would hit an all-time high, referencing an ounce of gold that commanded a $1,515 asking price. As the value of the U.S. dollar weakens, the demand for gold is inversely rising. Known as a safe-haven asset, gold tends to see increased levels of demand during times of consumer fear or recession.

Management

Sandy MacDougall – Chairman and Director
An economics graduate from the University of British Columbia, Sandy MacDougall brings 30+ years of experience in the investment banking and finance industry to KGS. He was instrumental in the acquisition, development and production of gold at the Alto el Toro mine near Ibaguel, Columbia. As a former investment advisor at Canaccord Capital Corp., MacDougall was a key player in multiple significant financings in Canada as well as abroad, working with a wide range of companies. His experience has afforded him critical exposure to precious and base metal projects throughout North and South America, and he has served as chairman of the board since 2016.

Arthur Brown – President and Director
With 36 years of business experience and service to the boards of eight other companies in sectors ranging from technology to oil, gas and mineral exploration, Arthur Brown adds substantial knowledge in corporate structure and development as well as financings and venture capital to the KGS team.

Cyrus Driver – Independent Director
Cyrus Driver was a founding partner in the firm of Driver Anderson from its inception in 1982 and is a chartered accountant as well as a retired partner in the firm of Davidson and Company LLP. Aside from providing general public accounting services to a diverse range of clients, his specialty is servicing TSX Venture-listed companies and members of the brokerage community. With expert knowledge of the securities industry and its regulations, Driver lends valuable advice to his clients regarding finance, taxation and other accounting-related matters. He currently serves as director and chief financial officer of several TSX-V-listed companies.

Dr. Peter Born – Director and Technical Specialist
A professional geologist registered with the Association of Professional Geoscientists of Ontario and a fellow of the Geological Association of Canada, Dr. Peter Born brings 30+ years of experience in exploration and mining to the company. With prior roles as a senior geologist with Western Mining Corporation, he is currently working with RPS Energy Canada Ltd. on natural gas plays related to high-temperature dolomites and sedimentary zinc deposits (MVT) within the Appalachian Basin in the United States. Dr. Born holds a Ph.D. in earth sciences and has expertise in Precambrian sedimentary geology, basin analysis, sedimentology, stratigraphy and sedimentary ore deposits.

Kingman Minerals Ltd. (TSXV: KGS), closed Thursday's trading session at $0.18, even for the day, on 11,260 volume. The average volume for the last 3 months is 36,054 and the stock's 52-week low/high is $0.09/$0.22.

Recent News

The Movie Studio Inc. (OTC: MVES)

The QualityStocks Daily Newsletter would like to spotlight The Movie Studio Inc. (OTC: MVES).

While government-imposed lockdowns have crippled the film industry, video-streaming services have seen increased demand (http://nnw.fm/y4Iqb). The Movie Studio Inc. (OTC: MVES), a vertically integrated motion picture production company, is positioned to benefit from this shift by continuing to acquire, develop, produce and distribute independent motion pictures globally via subscription and advertiser video on demand (SVOD/AVOD), over the top (OTT) platforms, foreign sales and various media devices. Also today, NetworkNewsWire released a report on the company detailing today’s corporate overview from MVES President and CEO Gordon Scott Venters. To view the full press release, visit http://nnw.fm/UQ8jO

The Movie Studio Inc. (OTC: MVES) is a vertically integrated motion picture production company focused on acquiring, developing, producing and distributing independent motion picture content for worldwide consumption via subscription and advertiser video on demand (SVOD/AVOD), over the top (OTT) platforms, foreign sales and various media devices. The company is currently engaged in establishing its own OTT VOD platform to integrate both its own and aggregated feature film projects, television programming and other media intellectual properties. The Movie Studio is disrupting traditional media content delivery systems with its digital business model of motion picture distribution, and the company intends to create a direct server access platform of its content with geo-fractured territories for worldwide distribution.

The company has launched The Movie Studio App on Google Play and the App Store, enabling users to both view the company’s content and potentially become part of it. The app is in the completion stage, and The Movie Studio is conducting its final beta test of the app’s unique “audition submission” function, leveraging the company’s “Watch Our Movies, Be in Our Movies!” content platform and “Everyone’s a Star” campaign, which will be marketed via social media. Using the app, subscribers can upload a thumbnail photo of themselves along with a selfie video audition submission that showcases them reading character dialog. Audition submissions will then be reviewed by producers for possible participation of the auditionee in upcoming feature films.

The audition submission function provides the subscriber the ability to disrupt traditional motion picture casting and management, enabling access to participation in The Movie Studio’s independent motion picture and media content. At the same time, for the company this significantly reduces capital expenditures associated with those traditional media mechanisms. The Movie Studio’s unique business model capitalizes on the global demand for film content through the production and distribution of its own films while also providing opportunities for direct viewer involvement in its content.

The company operates using a growth-by-acquisition strategy that includes:

  • Purchasing legacy film libraries.
  • Upgrading acquired films to 4K resolution and remonetizing with “new” film content on popular VOD streaming platforms across the internet.
  • Strategic partnerships and media content alignment with other OTT platforms and cross-collateralization of leverageable media assets for worldwide distribution.
  • Producing micro-budget motion picture content with substantial production value utilizing new 4K technology and the company’s extensive legacy resources and unique production process, thereby significantly reducing capital expenditures while allowing for the potential of significant return on investment (ROI) with one successful production.
  • Controlling its revenue streams through server-driven geo-fracturing global territories and its own OTT platform.

Currently, The Movie Studio is producing three upcoming feature films: “Cause and Effect,” “The Last Warhead” and “PEGASUS” — all with completed electronic press kits and pitch decks and fully produced motion picture-quality trailers ready for talent, distribution and financial integration.

The company has been successful in producing, casting and distributing its films on major SVOD platforms without recognizable stars, which reduces capital expenditures. However, The Movie Studio intends to integrate recognizable stars into the productions at value propositions either pre- or post-completion of the intellectual property.

Through successful beta testing, The Movie Studio has monetized film assets on the Amazon, tubi tv, Comcast and Showtime platforms.

The company’s proposed server-based model will provide licensing payment from global territories without third-party distribution fees, which have traditionally been as high as 35%.

Founded in 1961 and formerly known as Destination Television, Inc., the company changed its name to The Movie Studio, Inc. in November 2012. The Movie Studio is headquartered in Fort Lauderdale, Florida.

Cord-Cutting Creates Opportunity for VOD Players

Consumers are no longer content waiting for their favorite programming to come on the air – they expect instant streaming access where and how they want it. This has led to increased “cord cutting,” with consumers severing ties with their traditional pay TV providers in favor of digital streaming services.

With the advent of smart TVs with app integration, consumers can now watch what they want to watch when they want to watch it, fracturing traditional cable bundling mechanisms.

With pay TV usage steadily declining – satellite and cable TV businesses in the United States lost approximately 6 million customers in 2019 alone – streaming platforms are poised to potentially replace traditional pay TV distribution models altogether. Approximately 12,000 U.S. consumers are cutting the cord every day.

As this shift in media delivery continues and as digital devices become more sophisticated and bandwidth increases, VOD platforms have the potential to scale significantly. The Hollywood “streaming wars” of recent years have created an environment in which smaller competitors, like The Movie Studio, are able to emerge as major brands.

The Movie Studio Inc. (OTC: MVES), closed Thursday's trading session at $0.01, even for the day, on 244,575 volume with 15 trades. The average volume for the last 3 months is 99,946 and the stock's 52-week low/high is $0.0063/$0.07.

Recent News

Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR)

The QualityStocks Daily Newsletter would like to spotlight Energy Fuels Inc. (UUUU).

Energy Fuels (NYSE American: UUUU) (TSX: EFR), the leading uranium producer in the United States, on Wednesday reported results from the election of directors and other matters that were voted on at its annual meeting of shareholders, which was held virtually on May 27, 2020. Among other highlights, the company reported that the eight nominees proposed by management for election as directors were successfully elected by the shareholders through a mixture of votes by proxy and electronic poll. To view the full press release, visit http://nnw.fm/S6Sik

Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR), based in Lakewood, Colorado, is the country’s largest producer of uranium and the leading conventional producer of vanadium, both designated by the U.S. government as critical minerals.

As the leading U.S. diversified uranium miner, Energy Fuels’ uranium production portfolio stands apart in the world. Energy Fuels has more uranium production facilities, more production capacity, and more in-ground resources than any other company in the United States. In fact, the company’s assets have produced over one-third of all U.S. uranium over the past 15 years and is uniquely positioned to increase production to meet new demand.

Energy Fuels utilizes both conventional and in-situ recovery (“ISR”) technology to produce uranium from three strategic facilities:

  • White Mesa Mill in Utah (conventional) has a licensed capacity of over 8 million pounds of U3O8 per year. The highly strategic White Mesa Mill is the only conventional uranium mill in the country and is proximate to some of the largest and highest-grade uranium mines and projects in the U.S., including the Company’s Canyon mine, La Sal Complex, Henry Mountains Complex and Roca Honda Project. White Mesa Mill provides Energy Fuels with significant production scalability as uranium demand increases. The White Mesa Mill also has other diverse businesses, including vanadium, rare earth elements (REE’s), alternate feed materials recycling and land cleanup, all described below.
  • Nichols Ranch Plant (ISR) is located in the productive Powder River Basin district of Wyoming and has a total licensed capacity of 2 million pounds of U3O8 per year. Nichols Ranch has produced 1.2 million pounds of U3O8 since commissioning in 2014, and it has significant future expansion potential from 34 fully licensed wellfields containing significant in-ground uranium resources.
  • Alta Mesa Plant (ISR) is located on over 200,000 acres of private land in Texas. The fully licensed and constructed ISR project has a total operating capacity of 1.5 million pounds of uranium per year and produced nearly 5 million pounds of U3O8 between 2005 and 2013. This low-cost production facility is currently on standby, maintained in a state of readiness to respond to expected increases in demand.

In addition to being the largest uranium miner in the U.S., Energy Fuels’ overall portfolio also includes a pipeline of high-quality, large-scale exploration and development projects that are permitted or are in advanced stages of permitting, as well as an industry-leading U.S. NI 43-101 Mineral Resource portfolio.

FACTOID: Energy Fuels has led industry efforts over the past two-plus years to get the U.S. government to recognize the importance of domestically produced uranium, including the 2018 – 2019 Uranium Section 232, the ongoing Nuclear Fuel Working Group and the recently announced creation of the U.S. strategic uranium reserve. The U.S. is by far the largest consumer of uranium in the world, yet we import almost all of our requirements; Energy Fuels aims to change that.

Nuclear Market Potential

Multiple studies in top scientific journals have shown that nuclear power is cleanest and most economical way to produce reliable electricity as worldwide demand continues to soar. Nuclear power is presently the only available and affordable low-carbon power source that can meet both current and future baseload electricity demands while simultaneously reducing air pollution and mitigating climate change. U.S. nuclear power plants currently generate nearly 20% of the nation’s electricity overall and 55% of its carbon-free electricity and even a modest increase in electricity demand would require significant new nuclear capacity by 2025. According to the World Nuclear Association (WNA), there are currently 441 operable reactors, with another 54 units under construction and 439 in various stages of planning; in addition, the WNA has identified a potentially massive supply/demand gap through 2040 of 1 billion pounds. These factors among others are expected to significantly drive increased demand for uranium.

Reasons Nuclear is Gaining Traction

  • Nuclear reactors emit no greenhouse gases during operation. Over their full lifetimes, they result in comparable emissions to renewable forms of energy such as wind and solar.
  • Unlike any other form of energy, the waste from nuclear energy is contained and managed securely. Used fuel is currently being safely stored for ultimate disposal or future reprocessing, and 96% of this waste can potentially be recycled.
  • Greater demand for clean electricity to power everything from homes to automobiles, reducing dependence on fossil fuels.

No. 1 U.S. Producer of Vanadium in 2019

Energy Fuels also produces vanadium as a byproduct of uranium production. Vanadium is designated a critical mineral, essential to the economic and national security of the United States. Energy Fuels was the largest producer of vanadium in the U.S. in 2019, and has significant high-grade, in-ground vanadium resources, as well as a separate high-purity vanadium production circuit at their White Mesa Mill, which is also the only conventional vanadium mill in the country. Crucial for use in the steel, aerospace, and chemical industries, vanadium plays a critical role in the production of high-strength and light-weight metallic alloys and demand is expected to increase across the globe.

Energy Fuels has several fully permitted and developed standby mines containing large quantities of high-grade vanadium, along with uranium, including:

  • La Sal Complex (Utah)
  • Whirlwind Mine (Colorado/Utah)
  • Rim Mine (Colorado)

Vanadium has also gained increased attention as a catalyst in next-generation high-capacity, “community-scale” batteries used for energy storage generated from renewable sources. Demand is only expected to grow as this market expands. With recent upgrades in its vanadium production operations, in 2019 Energy Fuels produced commercial levels of the highest purity (99.7%) vanadium in the mill’s history and can rapidly adjust production to meet volatile market conditions. Energy Fuels is one of the very few known avenues that provides investors access the vanadium market.

Rare Earth Element (REE) Production, Alternate Feed Material Recycling, and Land Cleanup

The White Mesa Mill also provides the company with diverse cashflow generating opportunities. Security of supply for Rare Earth Elements (REEs) supporting U.S. military and defense requirements is a major issue today. Energy Fuels has been approached by a number of entities, including the U.S. government, inquiring about the potential to process certain REEs at the mill. The White Mesa Mill is currently licensed to process certain REEs, including tantalum and niobium. And, early indications are that the mill can be utilized to produce several other REEs. The White Mesa Mill is also the only facility in North America licensed and capable of recycling alternate feed materials (AFMs). AFMs are essentially low-level waste materials that contain recoverable quantities of natural (or unenriched) uranium. The Company typically generates between $5 and $15 million per year from AFM recycling. Finally, Energy Fuels is seeking to become involved in the cleanup of legacy Cold War era uranium mines in the Four Corners region of the U.S., including on the Navajo Nation. The U.S. Environmental Protection Agency (EPA) has access to over $1.5 billion for the cleanup of just a fraction of the sites on the Navajo Nation. The White Mesa Mill is fully licensed to receive much of this material, we are one of the government’s lowest cost options, and we have the ability to recycle the material and produce usable uranium from it.

Management Team

Mark S. Chalmers, President and CEO
Mark S. Chalmers is the president and chief executive officer of Energy Fuels, a position he has held since Feb. 1, 2018, following his role as chief operating officer of Energy Fuels from July 1, 2016 – Jan. 31, 2018. From 2011 to 2015, Chalmers served as executive general manager of Production for Paladin Energy Ltd., a uranium producer with assets in Australia and Africa, including the Langer Heinrich and Kayelekera mines where, as head of operations, he oversaw sustained, significant increases in production while reducing operating costs. He also possesses extensive experience in in situ recovery (“ISR”) uranium production, including management of the Beverley Uranium Mine owned by General Atomics (Australia), and the Highland mine owned by Cameco Corporation (USA). Chalmers has also consulted to several of the largest players in the uranium supply sector, including BHP Billiton, Rio Tinto, and Marubeni, and until recently served as the chair of the Australian Uranium Council, a position he held for 10 years. Chalmers is a registered professional engineer and holds a Bachelor of Science in Mining Engineering from the University of Arizona.

W. Paul Goranson, COO
W. Paul Goranson is the chief operating officer for Energy Fuels. Goranson has 30 years of mining, processing and regulatory experience in the uranium extraction industry that includes both conventional and in-situ recovery (“ISR”) mining, and he is a registered professional engineer. Prior to the acquisition by Energy Fuels of Uranerz Energy Corporation, Goranson served as president, chief operating officer and director for Uranerz, where he was responsible for operations of the Nichols Ranch ISR Uranium Project. In addition to those duties, he also managed uranium marketing, regulatory and government affairs, exploration and land. Prior to joining Uranerz, Goranson served as president of Cameco Resources, where he led the operations at the Smith Ranch-Highland, Crow Butte and North Butte ISR uranium recovery facilities. Goranson also served as vice president of Mesteña Uranium LLC, and he has served in senior positions with Rio Algom Mining, (a subsidiary of BHP Billiton), and Uranium Resource Inc. Goranson has a Bachelor of Science in Natural Gas Engineering from Texas A&I University, and a Master of Science in Environmental Engineering from Texas A&M University-Kingsville.

David C. Frydenlund, CFO, General Counsel, Corporate Secretary
David C. Frydenlund is chief financial officer, general counsel, and corporate secretary of Energy Fuels. His responsibilities include oversight of all legal matters relating to the company’s activities. His expertise extends to NRC, EPA, state and federal regulatory and environmental laws and regulations. From 1997 to 2012, Frydenlund was vice president of regulatory affairs, general counsel and corporate secretary of Denison Mines Corp., and its predecessor International Uranium Corporation (“IUC”). He also served as a director of IUC from 1997 to 2006 and CFO of IUC from 2000 to 2005. From 1996 to 1997, Frydenlund was vice president of the Lundin Group of international public mining and oil and gas companies, and prior thereto was a partner with the Vancouver law firm of Ladner Downs (now Borden Ladner Gervais) where his practice focused on corporate, securities and international mining transactions law. Frydenlund holds a bachelor’s degree in business and economics from Simon Fraser University, a master’s degree in economics and finance from the University of Chicago and a law degree from the University of Toronto.

Curtis H. Moore, Vice President of Marketing and Corporate Development
Curtis H. Moore is the vice president of Marketing and Corporate Development for Energy Fuels. He oversees product marketing for Energy Fuels, and is closely involved in mergers & acquisitions, investor relations, public relations, and corporate legal. He has been with Energy Fuels for over 12 years, holding various roles of increasing responsibility. Prior to joining Energy Fuels, Moore worked in multi-family real estate development, government relations and public affairs, production homebuilding, and private law practice. Moore is a licensed attorney in the State of Colorado. He holds Juris Doctor and MBA degrees from the University of Colorado at Boulder, and a Bachelor of Arts dual degree in Economics-Government from Claremont McKenna College in Claremont, California.

 

Energy Fuels Inc. (UUUU), closed Thursday's trading session at $1.63, off by 2.9762%, on 1,507,805 volume with 4,163 trades. The average volume for the last 3 months is 1,692,416 and the stock's 52-week low/high is $0.779999971/$3.31999993.

Recent News

Exro Technologies Inc. (CSE: XRO) (OTCQB: EXROF)

The QualityStocks Daily Newsletter would like to spotlight Exro Technologies Inc. (OTCQB: EXROF).

Canada-based Exro Technologies Inc. (CSE: XRO) (OTCQB: EXROF), one of the world’s proven leaders in the innovation of electric motors, has seen impressive success since the appointment of new CEO Sue Ozdemir late last year. Recognized as an accomplished executive and industry expert with more than two decades of accomplishments in the electric motor industry, including nine years at General Electric, Ozdemir has identified clear objectives for Exro with actual delivery on five major signed agreements since she joined the company.

Exro Technologies Inc. (CSE: XRO) (OTCQB: EXROF), a Canadian technology company, is an innovative pioneer in the energy sector. Exro has developed and commercialized an electric power module (EPM) that integrates into existing motor systems to make them smarter. Exro’s patented technology optimizes existing motor performance by automatically sensing and adapting operating parameters to an optimized state, creating measurable efficiency gains, reduced mechanical components and increased system availability.

Applications

Exro’s technology and efficiency optimization algorithms improve the performance and efficiency of electric motors by manipulating power delivery to individual coils, thereby enabling the ability to expand operating parameters. This novel approach is scalable and can be utilized in most variable torque applications.

The widespread applications of Exro’s technology apply to optimizing the performance of electric vehicles, locomotive traction applications, industrial motors, and other variable torque applications that benefit from smart energy conversion.

Intellectual Property

Exro’s proprietary, patented software controls electric motor coils through individual coil switching. This introduction of intelligence into energy conversion at the level of individual coils results in expanded speed/torque capability, improved machine efficiency, reliability, safety and maintenance across a wider operating range. Exro’s advanced control algorithms create smart, real-time optimized power management.

Exro currently holds 15 patents, with 8 patents pending and additional patents under development. The company continues to expand its IP portfolio to support its goal of becoming a globally recognized leader in leveraging advanced control algorithms to improve the performance, efficiency and longevity of electric motors and generators.

Market Opportunity

Electric motors are the single biggest consumer of electricity. They account for about two-thirds of industrial power consumption and about 45% of global power consumption, according to an analysis by the International Energy Agency. Exro’s technology seeks to give industries a new way to look at energy—from electric vehicles, to industrial equipment, to renewable applications like wind farms; we are improving the way energy is consumed.

Laboratory Expansion

The 6,500-square-foot Exro Innovation Center (EIC), scheduled to open spring of 2020 in Calgary, will transition the current Victoria lab into one Calgary based center. The company’s new laboratory space will expand its service capabilities to customers, provide larger test capabilities, and showcase how Exro’s technology can be applied to dramatically improve the performance of electrical motors.

The EIC will also host collaborative events to explore advances in energy consumption and electric motor innovations, with participants from across Canada and around the world.

Strategic Partnerships

  • A strategic agreement with Finland’s Aurora Powertrains Oy, which in 2019 released an all-electric production snowmobile called the “eSled,” will see Exro’s technology added to the Aurora electric powertrain. The snowmobile sector’s economic footprint is estimated at $26 billion in the U.S., $8 billion in Canada, and $5 billion in Europe and Asia.
  • An agreement with Potencia in Mexico serving the last mile vehicle segment will integrate Exro’s custom drive and EPM module into small passenger commercial vehicles (taxis) and fleet delivery trucks
  • A licensing agreement with Motorino Electric, a leader in the Canadian electric transportation industry, will integrate Exro’s Electric Power Module technology into Motorino’s CTi electric bicycle.

Management

Chief Executive Officer Sue Ozdemir is a proven leader in the innovation and manufacturing of electric motors. She has nine years of accomplishments at General Electric, acting as CCO and the CEO of GE’s Small Industrial Motors Division, overseeing the division’s North American and international markets – ultimately building the division into a $160 million enterprise.

Chief Commercial Officer Josh Sobil is leading the seamless adoption of Exro’s growing product portfolio focused on the mobility segment and opening doors in all segments including agriculture, heavy industry, energy, construction, among others.

Executive Chairman Mark Godsy is a serial technology entrepreneur who has been involved in many top tier ventures, including two of Canada’s most successful biotech companies.

Exro Technologies Inc. (CSE: XRO) (OTCQB: EXROF), closed Thursday's trading session at $0.3904, off by 3.0062%, on 228,287 volume with 105 trades. The average volume for the last 3 months is 169,319 and the stock's 52-week low/high is $0.124389998/$0.522899985.

Recent News

InsuraGuest Technologies, Inc. (TSX.V: ISGI)

The QualityStocks Daily Newsletter would like to spotlight InsuraGuest Technologies, Inc. (TSX.V: ISGI).

InsuraGuest Technologies (TSX.V: ISGI) offers innovative ideas and solutions to revolutionize outdated business models and systems. To view the full article, visit http://nnw.fm/vdVH0

InsuraGuest Technologies, Inc. (TSX.V: ISGI) is a leading global SaaS (Software-as-a-Service) company leveraging its proprietary, flagship insurtech (insurance + technology) software, InsuraGuest, which is integrated with the property management systems of hotels and vacation rentals to deliver custom Hospitality Liability coverages.

InsuraGuest’s Hospitality Liability coverages are purchased by hotels and vacation rental properties, which can address claims from guests and their room occupants. The combination of the integrated software and customized insurance provides the property liability coverages the guests benefit from in the event a loss is incurred during their stay.

The Hospitality Liability policy is offered through integration of InsuraGuest’s API with the clients’ property management systems. InsuraGuest’s platform is currently capable of integrating with approximately 71 different hotel and vacation rental property management systems, giving it access to millions of rooms worldwide.

InsuraGuest continues to pursue expansion opportunities in the United States, and has plans to expand to its distribution platform and Hospitality Liability coverages to the United Kingdom and Europe regions by third quarter 2020, as well as expansion into Asia by the end of 2020.

Protection that Enhances the Guest’s Experience

InsuraGuest’s Hospitality Liability coverages add a layer of protection for the property on a primary basis, should a guest experience an accident or theft while staying at an InsuraGuest member hotel or vacation rental property.

Market Opportunity

The U.S. hotel industry generated more than $218 billion in annual revenues in 2018, an increase of $10 billion from the previous year, according to STR’s 2019 HOST Almanac. The European market is more than double the size of the U.S. market. According to Oxford Economics, there were 6.4 billion nights stayed in the world, with 2.6 billion hotel nights stayed in Asia, 2.8 billion nights stayed in Europe, and 1.1 billion stayed nights in the United States. Additionally, $100 billion was spent on vacation rentals in the United States, where there approximately 4.5 million second homes are being managed by a third-party rental company.

With distribution in Europe and the United States, InsuraGuest’s combined demographics will total 3.9 billion nights stayed, and will more than double its vacation rental opportunities.

Within this burgeoning, high-demand industry is risk of liability to guest injury. For example, gym injuries are among the top five most common hotel accidents. Without proper hedges in place, the property may be liable in a personal injury claim or lawsuit that are not the properties fault.

Though the potential for accidents, slip and falls and mishaps can be widespread, it can be covered under the InsuraGuest Hospitality Liability policy to provide guests a worry-free and enjoyable stay that potentially increases loyalty for the property.

Investment Consideration

  • Targeting hotels and vacation rentals, a multi-billion-dollar industry
  • Providing the first line of defense in case of accident, loss or death
  • Expanding distribution reach with footing in European hotel and vacation rental markets
  • Expansion into Asia by 2020

Executive Team

Douglas Anderson, Chairman & Chief Executive Officer
Douglas Anderson has been a businessman in the real estate industry for nearly 30 years. His business expertise includes master planning and development implementation for larger-scale resorts, business parks and commercial developments across the USA and two provinces in Canada. His business endeavors include the founding of the 7th larger private equity fund in America focusing on multifamily and senior care (ROC Fund/Bridge IPG Fund). He serves as chairman/founder of a golf and winter sports ski holding company with operations in four major east coast markets and British Columbia, Canada.

Anderson earned a Bachelor of Science in consumer studies with an emphasis in architecture as an undergraduate at the University of Utah. He subsequently earned his MBA. He also attended a three-year OPM Program a postgraduate business education at Harvard Business School in Boston. Anderson is an avid skier and outdoor enthusiast.

Logan Anderson, CFO & Director
Logan Anderson (bachelor’s degree in communications, accounting and economics) holds the designation of ACA with the Chartered Accountants of Australia and New Zealand. He began his career as an associate chartered accountant in New Zealand and then Canada. This was followed by his position as controller of a management services company which was responsible for the management of numerous private and publicly traded companies. Since 1993, Anderson has served as president of Amteck Financial Corp. (and its predecessors), a private financial consulting services company servicing both private and public companies. He is a former director of 3D Systems, Inc. (NYSE: DDD), and was formerly a founder, officer, and director of Worldbid.com. Anderson has also been involved in raising funds for numerous private and public companies in all stages of their development and has been an officer and director for numerous public and private companies over the past 40 years.

Charles James Cayias, President & Director
Charles James Cayias is also the president and owner of Charles James Cayias Insurance Inc. He is a third-generation insurance professional whose creativity and artistic vision have enabled him to establish a full-service agency combined with the personal service each client deserves. His outstanding people skills, honesty, integrity and fairness are evident by his loyal and growing clientele, the majority of which are referrals who become long-time customers and friends. Cayias began his insurance career in the early 1970s and has been licensed since 1977. He is licensed in all 50 states and specializes in niche programs. He has extensive expertise in all aspects of the insurance industry including commercial insurance, employee benefits, workers’ compensation, professional liability, risk management and bonding.

Tony Sansone, COO & VP of Finance
Tony Sansone has over 30 years of financial, operations and business development experience which includes serving as CFO in the health care, foodservice distribution, manufacturing and technology sectors, including public company experience. He has held senior finance positions in the banking, telecommunications, medical products, and food & drug retailer industries, closing over $430 million of private debt, equity and line of credit financings and over $350 million of a merger, acquisitions, real estate and state incentive transactions, including due diligence, negotiations, closing, and integration. Sansone coordinated and was the executive sponsor for four ERP implementations and multiple other best-in-class software & technology solutions. He received his MBA from the University of Utah and a Bachelor of Science in accounting from Utah State University. Sansone also currently serves as president-elect of the Utah Chapter of Financial Executives International and a past president and current member of the board of trustees for Catholic Community Services of Utah. He is the proud father of three children.

Christopher J. Panos, Vice President & Director
Christopher J. Panos is a highly competitive sales professional with over 15 years of territory manager sales experience and an award-winning record of achievements. He is exceptionally well organized with a proven work history that demonstrates self-discipline, superb communication skills, and the initiative to achieve both personal and corporate goals. Panos is successful in building relationships with a large network of industry professionals in order to grow and maintain new and existing business, exceed new sales objectives and provide in-depth product training to authorized dealers and sales personnel.

Alexander Walker III ESQ, Corporate Counsel & Director
Alexander Walker III ESQ has served as director of the company since September of 2018 and as counsel to the company since July of 2018. Walker is an attorney and has been a member of the Utah Bar Association since 1987 and a member of the Nevada State Bar since 2003. His practice has involved general business litigation, in both federal and state courts, and transactional work, including securities offerings and registration, corporate formation and periodic reporting compliance. Walker has provided legal services to emerging businesses throughout his carrier and at times has served as an officer and board member as well as legal counsel public companies. His duties as legal counsel for a public company engaged in the business of ownership and operation of coal-producing properties in the western United States included oversight of corporate-related legal matters including securities reporting, corporate compliance, federal and state mining regulation, and employment law oversight. He also has served as the chair of the Mining Committee of the Energy, Natural Resources and Environmental Law Section of the Utah State Bar, a member of the board of directors of the South East Utah Energy Producers Association, the co-chair of the board of the Western Energy Training Center, a board member of the Utah Supreme Court Committee to Review the ABA Recommendations Regarding the Office of Professional Conduct, and a board member of the University of Utah Crimson Club.

Jennifer Epperson, Vice President of Sales
Jennifer Epperson has over 20 years of B2B sales experience with exceptional success history. She has grown and developed sales territories across multiple industries. Her ability to find and develop strategic relationships has given her top-level performance throughout her career. Epperson’s passion and knowledge provide an inherent ability to connect and retain relationships for the growth of the company. Throughout her professional career, she has achieved peak performance sales results and awards year after year. She captures the vision of the company and drives it forward with enthusiasm and expertise. Her commitment to providing an exceptional customer experience has been the key to her success.

Richard Matthews, Interim Financial Controller
Richard Matthews joined the InsuraGuest team in March 2019 as the interim financial controller. Leading the Finance and Audit team, Matthews is responsible for the delivery of financial services such as accounting, treasury, reporting, budgeting and insurance management, in accordance with legislative requirements and organizational policies and strategies. He has over 30 years of experience in providing professional services across a broad range of finance areas including compliance, business process, audit, and financial reporting. He holds a degree in accounting from the University of Utah and is a licensed CPA in the state of Utah.

Roger Bloss, Corporate Consultant & Board Advisor
Roger Bloss joined InsuraGuest in August of 2019 to advise the company and its board on hotel transactions, contributing his knowledge from more than 40 years in the hospitality industry. Bloss previously served in executive positions with several major hotel franchise companies and in 1996 founded Vantage Hospitality Group hotel brands. Under his leadership, Vantage became a Top 10 global hotel company and made the Inc. 500/5000 list of Americas’ fastest-growing private companies for eight straight years. Bloss was named Lodging Magazine’s “Innovator of the Year” in 2006 and 2010, and in 2009 earned a spot on HSMAI’s “Top 25 Extraordinary Minds in Sales and Marketing.” Bloss joined Red Lion Hotels Corporation (RLHC) in September 2016 in conjunction with the acquisition of Vantage.

Jim Kilduff, Board Advisor
James “Jim” C. Kilduff has nearly 40 years of experience in the insurance and risk management sectors. He is a dynamic and energetic team leader and builder with extensive experience in the changes affecting the insurance business through Gas, alternative distribution, insurtechs and program business. His skillset includes experience as chief insurance officer with Outdoorsy Insurance Group, CEO with Harbor Hill Solutions Inc., and senior vice president and chief marketing officer with State National Insurance Companies. His career has spanned MGA creation and management, insurance company management, business development and underwriting, primary insurance and reinsurance.

Don Archibald, Board Advisor
Don Archibald brings to InsuraGuest’s advisory board 54 years of experience as an insurance agent. Archibald is the founder and former owner of Archibald Clarke and Defieux (ACD Insurance), as well as the co-founder and former equity partner of Sussex Insurance, and an agent with Sussex since 2014.

InsuraGuest Technologies, Inc. (TSX.V: ISGI), closed Thursday's trading session at $0.14, even for the day, on 2,000 volume with 1 trade. The average volume for the last 3 months is 22,219 and the stock's 52-week low/high is $0.045/$0.34.

Recent News

SinglePoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight SinglePoint, Inc. (SING).

SinglePoint (OTCQB: SING) was featured in an Investorideas.com special snapshot reporting on the continued growth in sales and product offerings in the U.S. hemp industry and how this traction is beginning to attract outside investment (http://cnw.fm/Nqb0U). To view the full press release, visit http://cnw.fm/wv4Lp

SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.

SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.

SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:

  • A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
  • A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
  • A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
  • Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
  • Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
  • Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.

SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.

Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.

SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.

SinglePoint, Inc. (SING), closed Thursday's trading session at $0.00525, off by 0.943396%, on 6,852,249 volume with 133 trades. The average volume for the last 3 months is 5,302,551 and the stock's 52-week low/high is $0.004/$0.021999999.

Recent News

Genprex Inc. (NASDAQ: GNPX)

The QualityStocks Daily Newsletter would like to spotlight Genprex Inc. (NASDAQ: GNPX).

Genprex (NASDAQ: GNPX) today announced the exercise of warrants to purchase approximately 5.4 million shares of common stock issued in connection with capital raises in May 2018 and November 2019 with two institutional investors at a price of $0.46 per share, resulting in its receipt of approximately $2.5 million in cash proceeds. To view the full press release, visit http://nnw.fm/P2cIu

Genprex Inc. (NASDAQ: GNPX) is a clinical-stage gene therapy company developing potentially life-changing technologies for cancer patients based upon a unique proprietary technology platform, including Genprex’s initial product candidate, Oncoprex™ immunogene therapy for non-small cell lung cancer (NSCLC). Genprex’s platform technologies are designed to administer cancer-fighting genes by encapsulating them into nanoscale hollow spheres called nanovesicles, which are then administered intravenously and taken up by tumor cells where they express proteins that are missing or found in low quantities.

Research and Development

Genprex holds a portfolio of 30 issued and two pending patents covering its technologies and targeted molecular therapies. The company’s research and development program is focused on identifying and developing leading-edge gene therapies that can be used alone or in combination with other therapies for treatment of cancer.

Genprex’s initial product candidate is Oncoprex™, an immunogene therapy for the treatment of non-small cell lung cancer (NSCLC). Oncoprex works by interrupting cell signaling pathways that cause replication and proliferation of cancer cells, re-establishes pathways for apoptosis (or programmed cell death) in cancer cells, and modulates the immune response against cancer cells. Oncoprex has also been shown to block mechanisms that create drug resistance.

Preclinical research is being conducted with the goal of developing Oncoprex to be administered with targeted therapies in other solid tumors, and with immunotherapies in NSCLC and other solid tumors. In addition, Genprex has conducted and plans to continue research into other tumor suppressor genes associated with chromosome 3p21.3, as well as other potential applications of the company’s immunogene therapy platform.

Clinical Trials

Genprex is currently conducting the second phase of a phase I/II clinical trial at the University of Texas MD Anderson Cancer Center in Houston. The company plans to expand its clinical program by adding a new clinical study evaluating Oncoprex™ in combination with a checkpoint inhibitor for treatment of Stage IV or recurrent NSCLC. In research presented at the 2017 Annual Meeting of the American Association of Cancer Research in Washington, D.C., Genprex’s collaborators showed that TUSC2 in combination with PD-1 checkpoint inhibition has a significantly greater anti-tumor effect in lung cancer than either agent alone. The research also shows that TUSC2 in combination with PD-1 blockade has synergistic activity in upregulating natural killer (NK) cells, correlating with prolonged survival in mice.

TUSC2 (Tumor Suppressor Candidate 2) is a tumor suppressor gene that is absent or deficient in cancer cells of many different cancer types.

The Market

Genprex technologies seek to bridge a critical gap by combining with targeted therapies and immunotherapies to provide treatments to large patient populations who would otherwise not be candidates for those therapies or who have become resistant to them. Genprex technologies are being developed to overcome genomic limitations which are inherent in targeted therapies and immunotherapies in order to provide new treatment solutions to large cancer populations, such as those with lung cancer.

Each year, more people die of lung cancer than of colon, breast and prostate cancers combined. NSCLC is the most common type of lung cancer, accounting for about 85 percent of all lung cancers, according to the American Cancer Society (“ACS”). Despite radical advances in drug development and novel therapeutic standards, survival for late stage lung cancer has not improved significantly in the past 25 years.

Senior Management

Chairman and Chief Executive Officer J. Rodney Varner, JD, is a co-founder of Genprex and has served in these roles since August 2012. He has more than 35 years of legal experience with large and small law firms and as outside general counsel of a Nasdaq-listed company. Varner has served as counsel in company formation, mergers and acquisitions, capital raising, other business transactions, protection of trade secrets and other intellectual property, real estate, and business litigation. He is a member of the State Bar of Texas and has been admitted to practice before the U.S. Court of Appeals for the Fifth Court and the U.S. Tax Court.

Julien L. Pham, M.D., MPH, is president and chief operating officer of Genprex. In March 2013, Dr. Pham co-founded RubiconMD, a healthcare IT company that connects primary care providers to specialists for additional guidance and opinions on medical cases and served as its chief medical officer. He has served on the faculty at Harvard Medical School’s Brigham and Women’s Hospital and is a board-certified internal medicine doctor and nephrologist.

Ryan M. Confer, MS, has served as Genprex chief financial officer since September 2016. Confer has more than 10 years of executive experience in planning, launching, developing, and growing emerging technology companies and has served in the chief operating and chief financial roles for non-profit and for-profit entities since 2008. Confer has also served as an international business development consultant for the University of Texas at Austin’s IC2 Institute, where he focused on evaluating the commercialization potential of nascent technologies in domestic and international markets applicable to technology incubator programs associated with the University. Confer holds a BS in finance and legal studies from Bloomsburg University of Pennsylvania and an MS in technology commercialization from the McCombs School of Business at the University of Texas at Austin.

Jan Stevens, RN, is vice president of Clinical Operations. Stevens has nearly 20 years of comprehensive clinical operations experience in the biopharma industry and a specialization in early-to-late stage oncology companies. Stevens joined the company to help support the various clinical development programs for Oncoprex™.

Genprex Inc. (NASDAQ: GNPX), closed Thursday's trading session at $2.77, up 4.5283%, on 1,071,065 volume with 3,255 trades. The average volume for the last 3 months is 2,928,566 and the stock's 52-week low/high is $0.231000006/$7.0300002.

Recent News

Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF)

The QualityStocks Daily Newsletter would like to spotlight Canopy Rivers Inc. (RIV) (CNPOF).

Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, today announced a series of operational changes designed to optimize its organizational structure, streamline operations, and preserve and maximize cash-on-hand. According to the update, the company, as part of its strategic and operational review of the business, is implementing changes including a material reduction in the company's operating cash outflows; a focus on generating positive cash flow; and a focus on maximizing returns on existing assets. To view the full press release, visit http://cnw.fm/zGn7u

Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) is the venture capital investment platform of Canopy Growth Corporation (TSX:WEED, NYSE:CGC).

Canopy Rivers is a unique investment and operating platform structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers collaborates with Canopy Growth to identify strategic counterparties seeking financial and/or operating support. Headquartered in Toronto, Canada, Canopy Rivers has developed an ecosystem of complementary cannabis operating companies operating throughout the cannabis value chain.

Canopy Rivers, in collaboration with Canopy Growth, has established a diverse portfolio of cannabis industry investments that includes domestic and international companies, licensed producers, late-stage licensed producer applicants, pharmaceutical formulators, brand developers and distributors, retail networks, and technology and media platforms. Investments are customized for each counterparty and include a balanced mix of equity, debt, royalty and profit-sharing agreements.

Canopy Rivers’ expanding portfolio includes:

  • Agripharm Corp. (private) is an ACMPR licensed producer, acquired by Canopy Growth in January 2017. In November 2017 Agripharm completed a joint venture with globally recognized partners Green House Seeds and Organa Brands. Canopy Growth has sublicensed proprietary technology, trademarks, genetics, know-how and other intellectual property from Agripharm to distribute the suite of Green House and Organa Brands products across the country, when permissible.
  • CanapaR Corp. (private) owns 80% of CanapaR Italy, a Sicily-based company focused on developing and commercializing Italy’s local hemp cultivation industry through its partnership with the renowned Department of Agriculture at the University of Catania and its rapidly building extraction capabilities for the production of organic CBD oil. CanapaR Italy’s outsource farming model with local Sicilian farmers and its university partnership will provide it with a low-cost source of organic CBD oil, which is increasingly used as an input into new commercial products in the growing health and wellness industries.
  • Civilized Worldwide Inc. (private), is a media and lifestyle brand with offices in New Brunswick and California that embraces and highlights modern cannabis culture. Civilized aims to engage the millions of productive, motivated people who choose to enjoy cannabis responsibly as part of their lifestyle. Reaching 2+ million unique visitors per month, North America-wide, Civilized produces engaging content for and about people who enjoy cannabis responsibly.
  • James E. Wagner Cultivation Ltd. (TSXV:JWCA) was founded in 2007 by third generation agricultural and cannabis cultivators. JWC is the first entirely aeroponic producer of cannabis in Canada, and its patent-pending aeroponic production technology, called GrowthStormTM, allows for perpetual harvesting and improved yields. The company was issued a license to cultivate from Health Canada in January 2017 and a subsequent sales license in March 2018.
  • LiveWell Foods Canada Inc. (TSXV:LVWL) was established in 1993 as a nutritional lifestyle company, and operates in the production of fresh produce and food technology. The company’s O-Hemp division distributes bulk and retail hemp products through its existing channel partners. LiveWell entered into a strategic agreement with Canopy Rivers and Canopy Growth in April 2018.
  • PharmHouse (private) is a joint venture between Canopy Rivers and the principals and operators of leading North American greenhouse produce companies. PharmHouse has arranged to acquire a newly built 1.3-million-square-foot greenhouse located in Leamington, Ontario.
  • Radicle Cannabis Inc. (private) is an ACMPR-licensed cannabis company based in Hamilton, Ontario backed by a management team that brings extensive experience in regulated industries, retail distribution, tobacco and pharmaceutical development, as well as Award-winning cannabis horticulturist breeders and medical professionals.
  • Solo Growth (TSXV:ALZ) is a new cannabis retail concept that will operate locations under the name “YSS by Solo,” relying on the expertise of a management team comprised of founding shareholders, senior officers and board members of Solo Liquor Stores Ltd., a leading Canadian liquor retailer. Solo Growth was established through a recapitalization of Aldershot Resources Ltd.’s corporate structure that will allow the company to execute a new retail-focused cannabis business strategy.
  • Spot Therapeutics Inc. (private) is an applicant that was acquired by Canopy Growth in August 2017 to solidify its Maritimes expansion strategy and less than four weeks later Canopy Growth signed a supply MOU with the New Brunswick government. Canopy Rivers purchased the property and entered into a long-term lease and committed funding agreement with Canopy Growth.
  • TerrAscend Corp. (CSE:TER) cultivates high-quality cannabis in an indoor hydroponic facility, backed by a strategic investor boasting a strong background in the pharmaceutical space and an extensive portfolio of specialty pharma assets.
  • Vert Mirabel (private) is a joint venture that was established in December 2017 between Canopy Rivers, Canopy Growth, and Les Serres Stephane Bertrand. Bertrand is a large-scale greenhouse operator located in Mirabel, Quebec, and the largest grower of pink tomatoes in the country. With guidance and assistance from Canopy Growth, the greenhouse has been upgraded and retrofitted for cannabis production and was licensed by Health Canada in May 2018.

As the company’s portfolio continues to develop, each constituent benefits from opportunities to collaborate with Canopy Growth and among themselves. Canopy Rivers believes this formula results in an ideal environment for innovation, synergy and value creation for Canopy Rivers, Canopy Growth and across the entire Rivers ecosystem.

Canopy Rivers is led by an experienced team of qualified financial and technical professionals with deep industry experience and relationship networks. The company’s acting CEO and chairman is Bruce Linton, CEO of Canopy Growth and founder of Tweed Marijuana.

Canopy Rivers Inc. (CNPOF), closed Thursday's trading session at $1.06, up 3.4146%, on 154,491 volume with 208 trades. The average volume for the last 3 months is 97,770 and the stock's 52-week low/high is $0.371499985/$3.30999994.

Recent News

Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT)

The QualityStocks Daily Newsletter would like to spotlight Blue Hat Interactive Entertainment Technology (BHAT).

Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) today announced its entry into a three-year partnership with smart education service provider, Sutesen Information Technology Ltd. ("Sutesen"), to expand Blue Hat's Smart Immersive Education Classes, or "AR Immersive Classes" ("ARIC"), in Guangxi province, China. According to the update, the partnership aims to commercially launch ARIC in up to 1,000 Guangxi preschools in three years. To view the full press release, visit http://nnw.fm/f5PUI

Blue Hat Interactive Entertainment Technology (BHAT) is a cutting-edge creator, developer and operator of popular augmented reality (“AR”) interactive smart toys and educational games in China. Blue Hat’s mobile-connected entertainment platform connects physical items to mobile devices through wireless technologies, creating a unique interactive user experience in various mobile games, interactive educational materials and toys with mobile game features.

Blue Hat designs original toys and games that utilize augmented reality technology, motion capture technology, image recognition technology, voice control, light sense technology, infrared, levitation induction, and other trending scientific technologies to transverse the virtual with reality. Blue Hat creates a rich visual and interactive environment for users through the integration of real objects and virtual scenery. This combination provides users with a more natural form of human computer interaction, enhances a user’s perception of reality, and delivers a more immersive entertainment experience.

Proprietary Technology

Founded in 2010, Blue Hat’s proprietary technology, product research and development, marketing channels and brand operation are the cornerstones of the business. Blue Hat focuses on the combination of “online” and “offline” activity and the interaction between “entertainment” and “product” to create a high-tech entertainment platform combining mobile games and AR. With the help of computer graphics, motion capture technology, image recognition technology and visualization technologies, Blue Hat accurately “places” virtual objects into the physical world, creating a new and stimulating visual environment for users.

Blue Hat recently displayed a variety of its sci-tech products at the Guangzhou International Toy Exhibition in China including AR Racer, Elastic Bubbles, AR Space Track, AR Alloy Toy Car, AR Need a Spanking, 5D Animated Magic Aquarium, Bug Travelers, AR Picture Book and other interactive games and smart toys.

The company has multiple products in development including new generations of four primary product lines and two new product lines.

Patents and Copyrights

Blue Hat’s advanced AR technology in interactive entertainment is protected by 178 authorized patents with 44 patents in various stages of the application process.

Another 14 applications for Patent Cooperation Treaty, or PCT, have been filed for international patents. As of March 31, 2019, the company owns 645 copyrights for artwork, 71 registered trademarks and 27 software copyrights.

Sales and Marketing

There has been rapid growth in the toys and games industry in China over the last several years. Total retail sales of toys and games in China soared from RMB 111.8 billion in 2012 to RMB 276.5 billion in 2017 with an average annual growth rate of 19.9% in 2017. Blue Hat believes the company is well positioned with little competition as the toy industry rapidly shifts toward intelligent and interactive toys and games. Retail sales of electronic toys grew at 24% annually in 2017 while that of traditional toys grew at 7%.

In addition to a powerful ecommerce presence, Blue Hat has long-term relationships with partnered distributors that place the company’s AR interactive entertainment products into well-known international retail chains and retail outlets. Blue Hat’s integrated online and offline sales channels include e-commerce giants such as Amazon and Alibaba, retail chain stores and the company’s physical experience store located in Xiamen, China. Blue Hat plans to open or franchise approximately 100 additional stores in China by 2021.

Blue Hat’s community-based platform offers users a highly engaged and interactive community with online communication forums and offline social activities. The company advocates a new model of “teaching through lively activities” and combines AR technology with education, integrating its products into situational teaching, roleplaying and man-machine interaction. This novel educational experience helps realize optimal transformation of information, creating a knowledge and enhancing cognition.

Management

Director and CEO Xiaodong (Sean) Chen has over 20 years of experience creating, developing and producing toys and games related products. Chen earned his EMBA from Renmin University of China and has been chairman of the board of directors and general manager of Fujian Blue Hat Interactive Entertainment Technology Ltd. since August 2015.

CFO and Director Caifan, who has over 20 years of financial accounting and taxation experience, earned a degree in finance from Hunan University of Finance and Economics. He has served as director, deputy general manager and financial controller of Fujian Blue Hat Interactive Entertainment Technology Ltd. since August 2015.

Jianyong Cai, chief technology officer and director, has over 35 years of experience in data communication principles, communication network foundation, software engineering, communication network theory and technology and computer network architecture. He holds degrees in data communication principles, communication network foundation and software engineering from University of Science and Technology of China. He has been director, deputy general manager and chief engineer of Fujian Blue Hat Interactive Entertainment Technology Ltd. since January 2010.

Blue Hat Interactive Entertainment Technology (BHAT), closed Thursday's trading session at $1.23, up 29.2017%, on 15,625,000 volume with 47,900 trades. The average volume for the last 3 months is 141,854 and the stock's 52-week low/high is $0.630800008/$6.25.

Recent News

Predictive Oncology (NASDAQ: POAI)

The QualityStocks Daily Newsletter would like to spotlight Predictive Oncology (POAI).

Predictive Oncology (POAI) is a knowledge-driven precision medicine company focused on applying data and artificial intelligence (AI) to personalized medicine and drug discovery. The company applies its smart tumor profiling and AI platform to extensive genomic and biomarker patient data sets to build predictive models of tumor drug response to improve clinical outcomes for the cancer patients of today and tomorrow. The company has several tools that support its mission of bringing precision medicine to the treatment of cancer.

Through its subsidiaries, Predictive Oncology’s portfolio of assets includes the following:

  • A database of clinically validated historical and outcome data from patient tumors
  • An in-house Clinical Laboratory Improvement Amendments (CLIA)-certified lab
  • A “smart” patient-derived tumor profiling platform
  • An in-house bioinformatics artificial intelligence (AI) platform
  • A new computerized approach growing tumors in the lab to rapidly develop patient specific treatment options
  • An FDA-approved fluid collection and disposal system

Using these resources, and in collaboration with key players in the pharmaceutical, diagnostic and biotech industries Predictive Oncology is working to determine the best pathways for more individualized and effective cancer treatment.

Subsidiaries

Predictive Oncology leverages the synergies of its three wholly owned subsidiaries to bring precision medicine to the diagnosis of cancer.

Helomics applies artificial intelligence to its rich data gathered from the company’s trove of more than 150,000 tumors to personalize cancer therapies for patients as well as drive the development of new targeted therapies in collaborations with pharmaceutical companies. This database, the largest of its kind in the world, is comprised of ovarian, head and neck, colon and pancreas tumors. Helomic’s CLIA-certified lab provides clinical testing that assists oncologists in individualizing patient treatment decisions, by providing an evidence-based roadmap for therapy.

In addition to its proprietary precision oncology platform, Helomics offers boutique CRO services that leverage its TruTumor™ patient-derived tumor models coupled to a wide range of multi-omics assays (genomics, proteomics and biochemical), and an AI-powered proprietary platform (D-CHIP) to provide a tailored solution to its clients’ specific needs.

TumorGenesis is developing a new, rapid approach to growing tumors in the laboratory without the use of rats or mice, allowing for the identification of biomarkers indicative of cancer. This methodology “fools” the tumor into thinking it is still in the body. As a result, the tumor reacts as it naturally would, thereby increasing the accuracy of the biomarker. Once the biomarkers are identified, they can be used in TumorGenesis’ Oncology Capture Technology Platforms which isolate and helps categorize an individual patient’s heterogeneous tumor samples to enable development of patient-specific treatment options.

Skyline Medical’s patented, FDA-cleared STREAMWAY® System is the first true, direct-to-drain fluid disposal system designed specifically for medical applications such as radiology, endoscopy, urology and cystoscopy procedures. The STREAMWAY system is changing the way healthcare facilities collect and dispose of potentially infectious waste fluid by connecting directly to a facility’s plumbing system to automate the collection, measurement and disposal of waste fluids.

The STREAMWAY minimizes human intervention for better safety and improves compliance with Occupational Safety and Health Administration (OSHA) and other regulatory agency safety guidelines. The STREAMWAY eliminates canisters, carts and evacuated bottles, which reduces overhead costs and minimizes environmental impact by helping to eliminate the approximately 50 million potentially disease-infected canisters that go into landfills annually in the United Sates.

Skyline has achieved sales in five of the seven continents through both direct sales and distributor partners.

Competitive Advantage

Precision medicine has become the holy grail of cancer therapeutics. Data driven predictive models of tumors and their responses are critical in both new drug development and individualized patient treatment. The race has begun to model various tumors, which takes 5 to 7 years of clinical evaluation to establish historical and outcome data.

Predictive Oncology enjoys significant competitive advantage. The company already has a vast historical collection of tumors and related data, plus the ability to obtain existing associated outcome data. While others wait for outcome data, Predictive Oncology is in a unique and powerful position, working to deliver the promise of precision medicine to reality. Predictive Oncology already has the clinical data, including how a tumor responded to certain drugs, an in-house bioinformatics AI platform, and only needs to do the tumor sequencing. The significance is underscored by the collaboration with UPMC Magee-Women’s Hospital, designed to reveal which mutations responded to which drug then develop powerful predictive models for future testing and treatment.

Leadership Team

Dr. Carl Schwartz was appointed to Skyline Medical’s board of directors in March 2015 and became interim president and CEO in May 2016. Dr. Schwartz became CEO of Plastics Research Corporation in 1988, leading the company to become the largest manufacturer of structural foam molding products in the U.S. with more than $60 million in revenues and 300 employees by the time he retired in 2001. He holds a bachelor’s degree and DDS degree from the University of Detroit.

CFO Bob Myers has over 30 years of experience in multiple industries focusing on medical device service and manufacturing. He has spent much of his career as a CFO and controller. Myers holds an MBA in Finance from Adelphi University and a BBA in public accounting from Hofstra University.

Gerald Vardzel, President of Helomics, has over 25 years of healthcare executive management experience developing and implementing commercialization strategies and models for technology launches. His Go-To-Market expertise includes equity financing, strategic planning, market intelligence, M&A, and new market development in both start-up and established settings including fortune 500 market leaders. He has developed innovative solutions for both CLIA and FDA regulatory paths defining the delivery chains from discovery to clinical acceptance. Mr. Vardzel also has significant experience designing and implementing sales and marketing programs tailored not only to expand market share, but to empirically assess client satisfaction, strengthen business processes, and maximize profitability. Mr. Vardzel was previously Vice President of Corporate Development and Strategic Initiatives at Global Specimen Solutions. Furthermore, as an executive affiliate to the healthcare industry, he routinely consults for several small-to-mid sized private equity firms advising on, in part, the feasibility of acquisition targets. Mr. Vardzel graduated from the University of Pittsburgh.

Dr. Mark Collins, Chief Information Officer of Helomics, has held multiple executive roles in a variety of discovery, informatics and bioinformatics functions within global pharma, and founded three startup software companies in the machine learning and drug discovery space. In 2001, Dr. Collins worked for Cellomics (now part of Thermo Fisher Scientific), where he played a pivotal role in establishing the High-Content Cell Analysis market, building and commercializing several key informatics and bioinformatics products. After leaving Thermo Fisher, Dr. Collins developed and commercialized informatics solutions for clinical and translational research, specifically in the specimen tracking, omics data management and NGS analysis space, through key roles at BioFortis, Global Specimens Solutions and Genedata. Dr. Collins received his undergraduate degree in Applied Science from the University of Wolverhampton, UK and his Ph.D. in Microbiology from the University of Surrey, UK.

Predictive Oncology (POAI), closed Thursday's trading session at $1.51, off by 6.7901%, on 416,884 volume with 1,012 trades. The average volume for the last 3 months is 1,037,122 and the stock's 52-week low/high is $1.25/$8.50.

Recent News

SRAX Inc. (NASDAQ: SRAX)

The QualityStocks Daily Newsletter would like to spotlight SRAX Inc. (NASDAQ: SRAX).

SRAX Inc.'s (NASDAQ: SRAX) is a digital marketing and consumer data management technology company. SRAX’s technology unlocks data to reveal brands’ core consumers and their characteristics across marketing channels.

Through its BIGtoken platform, SRAX has developed a consumer-managed data marketplace where people can own and earn from their data, thereby providing everyone in the internet ecosystem choice, transparency and compensation.

SRAX’s tools deliver a digital competitive advantage for brands in the CPG, automotive, investor relations, luxury and lifestyle verticals by integrating all aspects of the advertising experience, including verified consumer participation, into one platform.

SRAX Verticals

  • SRAX Core: SRAX Core is a custom digital media management platform that enables brands and agencies to surpass the challenges of omnichannel marketing campaigns. It offers one comprehensive dashboard to manage digital media campaigns, inventory and reporting.
  • SRAX Social: SRAX Social is a free social media management tool that makes it easy for brands, agencies and individuals to grow their digital presence. It offers free and unlimited users, Facebook auto boosting, and a custom analytics dashboard. Its managed services team can also build and execute marketing plans for your unique specific needs.
  • SRAX IR: SRAX IR unlocks stock buyers’ behaviors and trends for issuers of publicly traded companies. The platform provides insights on shareholders and market makers, investor relations management, shareholder outreach tools and data-driven marketing.
  • SRAX Auto: SRAX Auto unlocks auto intenders’ data to create measurable connected experiences on the road to purchase. It offers proprietary auto intender profiles, multi touchpoint communication and custom location-based ads.
  • SRAX Shopper: SRAX Shopper delivers a cross channel, premium digital experience at scale to high value shopper audiences. It offers proprietary shopper profiles, cost per click pricing, and custom text and add to cart ad units.
  • SRAX Lux: Launched in June 2019, the SRAX Lux platform targets and reaches luxury consumers at luxury retail stores, high-end art, music, film, fashion and sports events, across all consumer devices.

BIGtoken

BIGtoken, available for download on the App Store and Google Play, revolutionizes data collection. BIGtoken is a platform that creates a secure and transparent environment for consumers to own and earn from their data. To date, there are 15.9 million BIGtoken registered users worldwide.

The optimization and monetization of data is a multibillion-dollar business. Worldwide spending on big data and business analytics solutions reached $166 billion in 2018 and is projected to surge to $260 billion by 2022. BIGtoken’s consumer vision is committed to delivering choice, transparency and compensation to the individual.

Through BIGtoken, consumers earn rewards when they opt into sharing their data and when that data is purchased. Consumers decide what data is shared, who can buy it and how it’s used, and advertisers reach real, responsive audiences. The benefit of this is two-fold: consumers know how their data is used and advertisers gain verified consumer data for targeting.

Users of the BIGtoken app can officially be paid in cash or gift cards in exchange for giving brands access to their anonymized data, answering questions, checking into locations, recruiting new members, and more. Users can deposit their earnings directly into PayPal accounts or be paid through gift cards from favorite retailers such as Walmart.

SRAX has also partnered with several high-profile, nonprofit associations to provide BIGtoken users the ability to donate their earnings. Partnerships include the American Heart Association, dedicated to fighting heart disease and stroke; HealthCorps, which helps high school students make better choices about health and physical fitness; and the ALS Association, which recently launched its Challenge Me campaign.

International Expansion

BIGtoken is formally launching into several international markets and partnering to foster local support. SRAX recently signed a joint venture with the Yash Birla Group to launch BIGtoken in India. Based in Mumbai, the Yash Birla Group, one of India’s largest conglomerates, has diversified interests in consumer and industrial products.

The partnership will bring BIGtoken’s platform to India, which has a digital population of 627 million. The India digital advertising market is $3.6 billion and is set to grow at a compound annual growth rate of 32%, making it one of the largest growing digital ad markets in the world.

SRAX Mexico is led by Moe Avitia, who has more than 18 years of experience in business development and building high-tech teams. SRAX Mexico includes a team of 90 employees, including 70 engineers.

BIGtoken Europe is currently evaluating data centers in individual countries for privacy laws.

Leadership

Christopher Miglino is CEO and founder of SRAX. He has spent the past 20 years working in the digital advertising space and has successfully launched and sold two internet companies. Both of these companies were sold to publicly traded companies on the NASDAQ. He has a detailed understanding of how technology interacts with brands.

Kristoffer Nelson is COO of SRAX and a founding member of BIGtoken. With over 15 years of technology and creative business experience, Nelson has been a guest speaker for Loyola Marymount University among other academic institutions, the National Association of Broadcasters, the IAB and numerous other professional and media organizations.

SRAX Inc. (NASDAQ: SRAX), closed Thursday's trading session at $1.73, up 1.7647%, on 62,640 volume with 197 trades. The average volume for the last 3 months is 57,329 and the stock's 52-week low/high is $1.04999995/$5.63000011.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.